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4 number of indole compounds are known
to occur in the animal and vegetable kingdoms. Bufo
tenin (N-dimethyl-5-hydroxytryptamine) was found by
Phisalix and Bertrand (1893) in the secretion of the
skin glands of the toad. Indole and its 3-methyl
derivative, skatole, are found in the large intest¬
ine of man (Herter, 1898; Hesbitt, 1899). p-indo-
lyl acetic acid stimulates the growth of plants and
is known as a plant hormone (Skoog, 1937; Haagen-
Smith, 1939).
These Indole compounds have no marked pharma¬
cological activity. Laidlaw (1912) described the
actions of tryptamine and it was used as an ecbolic
under the name of rutamine (Akimoto, 1937). The
stimulus to the pharmacological study of indole
compounds was prompted when the vasoconstrictor
principle, serotonin, present in cattle serum, was
Identified by the work of Rapport (1949) as 5-hydroxy-
tryptamine.
As 5-hydroxytryptamine is the only indole
compound/
2.
compound with marked biological activity so far
isolated from mammalian tissues and as it is also
the most active indole compound hitherto tested
(krspamer, 1953e), the present study has been under¬
taken to investigate the actions of this compound
on isolated tissues.
It seems possible that a substance which would
antagonise the actions of 5-hydroxytryptamine might
be valuable in various ways. It might provide
evidence for the identification of 5-hydroxytrypta-
mlne in tissue extracts. It might help those who
are interested in other pharmacologically active
substances by suppressing interference due to 5-
hydroxytryptamine. It might have direct actions of
its own which would provide a clue to the physio¬
logical function of the 5-hydroxytryptamine which is
found in tissues. It might even have some thera¬
peutic action.
The work presented in this thesis describes
mainly, the search for such an antagonist. The





Indole and its 3-methyl derivative
(skatole) are present in the large intestine as a
result of the constant action of putrefactive
bacteria (Mesbitt, 1899). Herter (1907) determined
the amount as 60 mg of indole and 10 mg of skatole
in 100 g of the faeces. It was thought that their
absorption from the gut might produce some effects
by "auto-intoxication". The earlier work on the
pharmacology of these compounds deals mainly with
their toxic effects and actions on the central
nervous system.
Considerable quantities of indole were admini¬
stered to dogs, both orally and parenterally, with¬
out any toxic effects (Jaffe, 1872; Baumann, 1876;
Mencki, 1876; Mesbitt, 1899). Rovighi (1898) found
that indole and skatole after intravenous injection
in rabbits produced torpor, widespread paresis,
feeble heart action and lowered temperature.
A. detailed account of the effects of indole in
the rabbit, dog, monkey and man was given by Herter
(1898). He found that the intravenous injection
of indole in both the rabbit and the dog was markedly
toxic to the nervous system. He obtained no
definite/
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definite results when a small, ring-tailed monkey
was fed with 0.1 per cent solution of Indole for two
months. A number of healthy men were able to take,
without discomfort, amounts much greater than those
ever found in the bowel.
Woolley and Newburg (1911) produced hypertrophy
of adrenals and slight interstitial changes in the
kidneys of rabbits and white rats by injecting indole
in doses greater than that normally found in the
intestine of man.
Okhoubo, working with Metchnikoff (1910) studied
the effects of these compounds on the blood vessels.
He injected indole and skatole repeatedly in rabbits
and found arterial changes with indole, but there was
no effect with skatole.
The effects of indole were studied by many other
workers (Ott and Ulman, 1907} Alvarez, 1924} Bleble,
1929} Houssay, 1936). Skatole was found to be less
toxic than indole (Brieger, 1879} Porcher and
Hervieux, 1905; Adami, 1914). Indole and skatole
inhibit the oxidation of glucose, sodium lactate and
sodium pyruvate by the brain (<^uastel and Wheatley,
1933). According to these authors, a disturbance
of the hepatic detoxlcating mechanism might lead to
the/
5.
the presence of more than the normal quantities of
these compounds in the blood and might produce
psychological reactions similar to those met with
in anoxaemia or in the early stages of narcosis.
Convulsions have been observed in frogs and
rabbits after the injection of indole (Christiani,
1878-1379; Brieger, 1879; Herter and Wakeman, 1899;
Danilewsky, 1908; Gautier, 1912, 1914; Bieble, 1929).
Bin-ichi-yanai (1935) extensively studied the problem
of indole convulsions in frogs and in warm-blooded
animals. He came to the conclusion that indole
excited the motor parts and depressed the excitabilit
of sensory elements in the spinal cord of these
animals. His experiments also showed that a-methyl
and p-methyl Indoles paralysed the nervous system
of frogs causing complete abolition of spontaneous
reflex and respiratory movements. The sensory
elements of the cord were especially susceptible to
these compounds which thus acted like indole in this
respect, but differed from the latter in their effects
on the motor elements of the spinal cord, on which
the latter exerted an excitant action. The action
of indole on the spinal cord of the frog closely
resembled that of pyrrol (Tominaga, 1933). Peinberg
and/
and McCullough (1944) applied indole directly to the
cerebral cortex of the dog and cat and also injected
it intravenously into these animals. They concluded
that it acted on many portions of the central nervous
system and the characteristic motor seizures observed
were of sub-cortical and, In certain cases, of spinal
origin.
The actions of Indole on blood pressure,
respiration, gastro-intestinal tract and the central
nervous system of the dog were restudied by Harold
and Peinberg (1939, 1942). They Injected indole
Intravenously In a dose of 30 mg/kg and observed a
fall In blood pressure, arrest of respiratory move¬
ments, diminished Intestinal tone, increased secretion
of saliva and mucous and spasmodic jerkings in the
limbs. All these effects disappeared in fifteen
minutes. The administration of atropine stopped
the salivary and mucous secretions, but did not
change other reactions. A dose of 60 mg/kg of
indole killed the animal In five minutes, and at
autopsy, a dilated heart, congestion of abdominal
vessels and a large amount of mucous in the trachea
and bronchi were found. The effects on the central
nervous/
7.
nervous system were similar to those observed by
Yanal (1935). The above authors also studied the
M.L.D. (minimum lethal dose) and M.C.D. (minimum
convulsive dose) in albino rats. The M.L.D. was
calculated as 37 mg per 100 g weight of rat and M.C.D.
as 14 mg per 100 g weight of rat.
Walesch and Rackow (1942) found that indole in
• 8
a molar concentration of 10 inhibited serum chol-
inesterase by 50 per cent and N-methyl indole was at
least twice as active.
Guggenheim and LSffler (1916) found that indole
produced first a rise and then a fall in the tone of
isolated strips of guinea-pig's intestine. Waddell
(1927) investigated the actions of Indole and skatole
on the excised heart of the frog, turtle, cat and
rabbit, and noted a diminution in amplitude, rate
and output in all these species.
Indole shortens the isolated rectus abdominis
of the frog and sensitizes this preparation to the
effect of acetylcholine (Torda and Wolff, 1945).
Skatole did not modify acetylcholine activity. The
effect of potassium was increased by both indole and
skatole.
Bunyatyon and Matinyon (1948) described the
anti-histamine effects of indole and skatole.
Ckatole/
8.
Skatole was the more powerful} 0.35 mg nullified the
effect of lpg histamine.
Izquierdo and 3toppani (1950) confirmed the
results of Torda and Wolff (1945) on the rectus
abdominis of the frog, but the effeot on the smooth
muscle was completely different. Both skatole and
Indole in small concentrations diminished the
response of the guinea-pig*a ileum to potassium and
acetylcholine. The inhibition was reversible.
Izquierdo and Stoppani (1953) confirmed the
results of Bunyatyon and Matinyon (1948) and also
found that indole and skatole diminished and pro¬
longed the response of the guinea-pig's ileum to
acetylcholine. Indole and skatole diminished the
tone of the colon of the guinea-pig, rat and mouse.
They also diminished the spontaneous contractions
of the duodenum of the rabbit and the uterus of the
rat, and the response of the latter to oxytocin.
These authors suggested, that as Indole and skatole
were normal constituents of the intestinal fluid
(Herter, 1907), they could play a role in intestinal




Tryptophan, the amino acid containing
the indole nucleus was discovered by Hopkins and
Cole (1902). Various indole derivatives such as
indole, skatole, indole propionic acid and indole
acetic acid have been linked with the fate of this
amino acid (Guggenheim and Lfcffler 1916). Trypto¬
phan, like other amino acids is pharmacologically
inactive.
Tryptophan-betaine (hypaphorine).
Hypaphorine was isolated by Greshoff
(1890) from the seeds of Erythrina hypaphorus and
was subsequently found in Erythrina variegata var.
orientalis by Maranon and Gantos (1932) and in
Erythrina indica by Rao, Rao and Geshadri (1938).
Its possible occurrence In beetroot shoots was
suggested by Von Lippmann (1916). It was synthes¬
ized by Romburg and Barger (1911).
Hypaphorine produces increased reflex irrita¬
bility, and later, tetanic convulsions in the frog,
but has little action on rats, pigeons, rabbits and
guinea-pigs (Plugge, 1893). Chen and Chen (1933a)




J3-indole-acetic acid stimulates the growth
of plants and is known as a plant hormone (hetero-
auxln). It is necessary for tuber formation and
the curling and bending of plants and is especially
present in young growing buds and the leaves (Bkoog,
1937; Haagen-imith, 1939). It is generally held
that p-Indole-acetic acid in green plants is derived
from tryptophan (Jones, Metcalfe and sexton, 1949).
It has been found in the urine of 78 per cent cases
of dementia praecox (Ross, 1913). Anderson, Lhimi-
kin and Leake (1936) observed in mice, the relative
toxicity of indole-acetic acid, indolbutyric acid
and indole-propionic acid, Indole-acetic acid
killed the animals at a dose level of 25 mg/kg, while
with indole-propionic acid and indole-butyric acid
100 mg/kg were required. Respiratory embarrassment
and failure were the toxic manifestations noted.
The toxic effects of indole-acetic acid were also
studied by Berthelot et Joseph Dieryck (1939).
Like indole and skatole, Indole-acetic acid sensi¬
tized the rectus abdominis of the frog to the effect
of/
11.
of potassium, while tryptophan was without this
action (Torda and Wolff, 1945). Indole-3-acetic
acid like skatole but unlike indole, did not modify
the action of acetylcholine on the rectus abdominis
of the frog.
Indole-e thylamlne (tryptamine ).
Tryptamine was first obtained by the actio:
I • I
of bacteria on tryptophan (Ewins and Laidlaw, 1910),
» ,
It was later synthesised (Swins, 1911; Majima and
Hoshino, 1925). The pharmacological actions of
tryptamine were first described by Laidlaw (1911-
1912).
Intravenous Injection in the cat or the rabbit,
produced a transient stimulant effect causing clonic
and tonic convulsions, tremors of the limbs and vaa-
constriction.
In the spinal cat, it produced a rise of blood
pressure which was less marked In anaesthetised
animals. Large doses of nicotine and ergotoxine
diminished the blood pressure response to half, while
curare had no effect. It stimulated several organs
containing plain muscle but the uteri of the rabbit
and guinea-pig were relatively Insensitive. The
action on the cat's uterus was interesting. The
virgin/
12.
virgin uterus of the cat was relaxed in vivo but con¬
tracted markedly when isolated and suspended in a
bath. The pregnant uterus of the cat was stimulated
in situ. Laidlaw considered the possibility of two
sites of action for tryptamine, on the ganglia and
directly on the muscle, Experiments to demonstrate
nicotine-like action on the superior cervical ganglia
and the splanchnic ganglia failed. He suggested
that tryptamine had an action on some peripheral
nervous structure, probably a peripheral neurone,
which did not survive excision, and concluded that
there was a close parallelism between the actions of
tryptamine and nicotine on the cat's uterus.
The sphincter as well as the dilator muscle of
the iris are stimulated by tryptamine. The sphincter
muscle being more powerful ultimately overcomes the
dilator muscle and produces slit-like pupil. The
effect on the pupil is not observable in cats anaes¬
thetised with chloroform or ether. The effect on the
pupil was produced by intravenous injection of the
drug in the animal. Hypodermic injection and direct




Tryptamine had a mild stimulant effect on the
intestine, a weak motor response on the isolated
retractor muscle of the penis of the dog and caused
marked contraction of the plain muscle of the bladder*.
The drug diminished the urine flow but this effect
soon passed off and was considered to be due to a
transient constriction of the arterioles of the
kidney.
Guggenheim and LBffler (1916) observed a stlmu-
lant effect of tryptamine on guinea-pig's ileum and
reported that the drug inhibited the action of hista¬
mine on this preparation.
The pharmacological actions of tryptamlne were
also studied by Shimizu (1916), Matsumura, Nemoto
(1924) and Go (1926). iieuchi (1927) studied the
action of tryptamine on isolated hearts of toads and
rabbits and on vascular preparations of these animals.
It was found that tryptamine increased the force of
the heart and caused constriction of blood vessels,
omall doses of the drug increased the rhythmic
activity of the gut but large doses produced
inhibition.
Chen and Chen (1933a)reported the same results
with tryptamine as Laidlaxv (1911). Tryptamine was




Held (1951) restudied the pharmacology of
tryptamine in detail. He confirmed most of the
results of Laidlaw (1911-1912). He observed a rise
of blood pressure in cats, dogs and rabbits preceded
by a fall. There was a rise of pressure in the
pulmonary artery or right ventricle which accounted
for the initial fall. The pressor response was
reduced by yohimbine; the same observation was also
reported by Raymond-Hamet (1941). The drug caused
bronchoconstriction. It contracted the nictitating
membrane, the effect being increased by denervation
and depressed by yohimbine. Isolated arterial strips
and rat's uterus were also stimulated by tryptamine.
Tryptamine (16 ^g/l.) stimulates the isolated heart
of venus mercenaria (Twarog and Page, 1953).
Sullivan (1922) succeeded in isolating indole-
ethylamine from the urine of pellagra patients. In
pellagra, just as in schizophrenia, stuporous and
catatonic states were known to occur.
Nieuwenhuyzen (1936) studied the effect of the
intravenous Injection of tryptamine in cats with the
idea that in pellagra and schizophrenia, tryptamine
metabolism might have been/
16.
been disturbed. He noticed salivation, narrowing
of pupils, negativism and catalepsy in the cat.
Tryptamine is oxidised by amine-oxidase (Ouggenheim,
1951).
N-methyl tryptamine.
This is identical with dipterin, which
occurs in Chenopodiaceen girgensohnla Diptera and
Arthrophytum leptocladum (Yurashevskli, 1939). It
has been synthesized (Manske, 1932; Hoshlno and
Kobayashi, 1935).
N-methyl tryptamine raises the blood pressure
of decerebrate cats, but is less active than trypta¬
mine and N-N-dimethyl tryptamine is still less active.
The N-N-N-trl-methyl tryptamine is the most active of
these methyl derivatives and has about 1/20 the
activity of adrenaline on the blood pressure (Chen
and Chen, 1933a). All three methyl derivatives of
tryptamine stimulate guinea-pig*s uterus and rabbit's
intestine, trl-methyl p-indolylethyl iodide is most
active on rabbit's intestine. None of them produced
any response of the rabbit's pupil.
q-methyl-fc-lndol ethylamine.
This compound was synthesized and its
pharmacological/
16.
pharmacological actions extensively studied by deki
(1929), both In vivo and in vitro.
Small and medium doses caused reflex excitabil¬
ity, respiratory stimulation and convulsions in the
frog, rat, mouse and rabbit.
The heart, in situ or isolated, was stimulated
by small doses but moderate doses diminished the
activity of the heart Peripheral blood vessels
were markedly constricted.
The rabbit's uterus was stimulated, the pregnant
uterus being more sensitive than the non-pregnant.
Ergotamine inhibited the action of the drug on the
uterus, but atropine did not affect its response.
The drug increased the automatic movements of rabbit's
intestine in low concentrations (1 in 100,000), but
higher concentrations (1 in 50,000) caused a lowering
of intestinal tone and of the frequency of contract
ions.
Ergotamine inhibited the effect of the drug on
the rabbit's intestine, but the action was not as
marked as on the uterus. Atropine did not modify
the response to the drug. It was suggested by Seki
(1929) that the drug had an action on the motor
fibres of the sympathetic; in small and moderate
doses/
17*
doses it stimulated, but in large doses it paralysed
them. He compared its actions with those of trypta-
mine and concluded that the new-synthetic compound
had practical advantages over the older drug, being
equally efficient as a uterine stimulant, while
weaker in its action on the heart and intestine.
fframlne (3-dimethylamlno-methyl indole).
Gramine (Donaxine) was detected by von
Euler and Hellstrbm in barley mutants (1932, 1933).
It was found in the leaves of Arnudo donax L (Muzza
and Stolfi, 1931, 1933 and Orechoff and Narklno,
1935). Von Euler and Brdtman (1935) first suggested
the identity of donaxine and gramine and represented
the alkaloid as 2-methyl amino-3-methyl indole. It
was synthesized by Wieland and Hsing (1936) and Kuhn
and Stein (1937).
The drug produces a moderate fall of blood
pressure In the cat or rabbit, while small doses
increase and large doses decrease the blood pressure
of the dog (Euler, Erdtman and Hellstr&m, 1936 and
Raymond-Hamet, 1937).
Low doses in the mouse produce excitation
followed by drowsiness, higher doses cause clonic
convulsions./
18.
convulsions. In frogs, low doses cause somnolence,
higher doses,paralysis. The drug produces bronchial
constriction, increase in tone of the urinary bladder
and the intestine of the cat and a fall of tempera¬
ture in the rat (Cupniewski and derafinowna, 1939).
It decreases the amplitude and rate of the isolated
heart contractions, causes Inhibition, preceded by
stimulation of peristaltic movements of the isolated
small intestine of the rabbit and contracts the iso¬
lated uteri of the rabbit, guinea-pig, rat and
Syrian hamster (Powell and Chen, 1945). It reduces,
but does not reverse the effects of adrenaline on the
blood pressure, intestinal movements and isolated
uterus.
Kats are more susceptible to toxic effects of
the drug than are mice. The toxicity was determined
by intravenous injection.
2-Methyl gramine is similar to gramine for its
effects but was 3-4 times more toxic than gramine
(Supniewski and Berafin-Gajewska, 1939).
Bufotenin.
Bufotenin was found by Phisallx and
Bertrand,(l893, 1902), in the secretion of skin glands
of the toad (bufo vulgaris). It was later isolated
from/
19.
from many toads (Handovsky, 1920; Chen, Jensen and
Chen, 1931-1932; Jensen and Chen, 1932).
The corresponding quarternary base bufotenidln
(Cino-bufotenin) was Isolated from the Chinese drug
'Chan Su' and from the skin secretion of many toads
(Chen, Jensen and Chen, 1931). 'Chan Su' was pre¬
pared from the secretions of the Chinese toad called
'Censo' by the Japanese (Jensen and Chen, 1936). It
was in the form of hard, dark-brown smooth round
cakes weighing about 56.1 to 82.3 grams. The manner
in which these cakes were made was kept secret by the
natives. It was interesting that the above workers







It was used as a haemostatic, cardia-vascular stimu¬
lant and analgesic and for a variety of other ailments.
That bufotenin and bufotenidin contained an
indole ring was first reported by Wieland, Hesse and
Mittasch (1931). The chemical structure of bufo-
tenin was also studied by Jensen and Chen (1932) who
expressed the opinion that these substances were
derivatives/
20.
derivatives of tryptamine. Their chemical structure
was finally established by Wieland, Kanz and Mittasch
(1934). Bufotenin was later synthesized (Hoshino
and Bhimodaira, 1935).
The pharmacological actions of bufotenin were
studied by Handovsky (1920) who observed a rise of
blood pressure in the rabbit and decerebrate cat,
contraction of an arterial ring and myosis in the cat.
Chen, Jensen ana Chen (1931-1932, 1932, 1933)
and Chen (1934) extensively studied the actions of
bufotenin derived from several toads. Several of
these bufotenins caused a rise of blood pressure in
the pithed cat and had a stimulant action on the iso¬
lated intestine of the rabbit and the guinea-pig.
They increased the force of the heart and had a
slight myotic action when applied locally.
The properties of the pure substance have been
studied by Raymond-Hamet (1941, 1942a 1942b, 1942c)
and by Erspamer (1946a). According to Raymond-Hame
(1942a) the rise of blood pressure after the admini¬
stration of bufotenin was due to stimulation of the
adrenal medulla. The uterus of the rat is stimu¬
lated by the drug,
Bufotenin is oxidised by amine oxidase (Erspamer,
1946a* Blaschko and Philpot, 1953).
Cino/
21.
Cino-bufotenin stimulates the frog's heart,
causes a well-marked rise of blood pressure in the
anaesthetised cat, rabbit and dog, powerfully con¬
tracts isolated small intestine of the rabbit; has
a weak excitant action on isolated uterus of the
rabbit and guinea-pig and produces a feeble myotic
action (Chen, Jensen, and Chen, 193lf Raymond-Hamet,
1943, Erspamer, 1946a), Its pressor action in the
pithed cat was l/lO of adrenaline iChen and Jensen,
1931).
Cino-bufotenin, on a weight basis, was approxi¬
mately one-half as active as 5-hydroxytryptamine but
had qualitatively similar reactions except in cats
where it was usually pressor when 5-hydroxytryptamine
was depressor (Page and McCubbin, 1953a). Yohimbine
inhibits the pressor effect of cino-bufotenin in the
dog (Raymond-Hamet, 1943).
It stimulates the Isolated heart of a mollusc
venus mercenaria but is 20-100 times less active
than 5-hydroxytryptamine (Twarog and Page. 1953).
Cino-bufotenin is also a strong inhibitor of




This was another Indole compound found
in the skin secretions of bufogama, bufoarenarum and
bufomarinus and also in the Chinese drug 'Chan Su'
(Wieland and Vocke, 1930> Wieland, Kanz and Mittasc'n,
1934 and Jensen, 1935). The chemical structure of
bufothionin was established by Wieland and Wieland,
(1937).
It is pharmacologically inactive (Erspamer,
1946a, 1952c).
Adrenochrome.
This substance was isolated and identi¬
fied as qulnone resulting from adrenaline oxidation
(Green and Richter, 1937). Its solution is very un¬
stable, red in colour and non-fluorescent. It does
not possess the classical sympathomimetic actions
(Green and Richter, 1937; Philpot, 1940 and Braconier,
Lebihan and Beaudet, 1943).
Adrenochrome is known to be an excellent haemo¬
static so far as capillary haemorrhage is concerned
(Derouaux, 1941, 1943; Roskam, Derouaux, Meys and
Gwalue, 1947). The lack of toxicity and absence of
any interfering sympathomimetic action are obvious
advantages (Bacq, 1947). It is as good a haemo¬
static as adrenaline and its action is maximal three
minutes/
23.
minutes after injection Uioskam and Derouaux, 1945).
Adrenochrome, like other quinones, catalyses
the inactivation of catechol amines and may play a
role in hypertension (Oster and Eobotka, 1943).
These investigators, by the administration of adreno-
chrome and its derivatives, lowered the blood press¬
ure in experimentally induced hypertensive rats but
no effect on the blood pressure of normal rats was
observed. There were no toxic manifestations.
The work of Martin (1945) and Eynder, Leva and
Oberst (1947) showed no change in the blood sugar
level with adrenochrome.
The actions of adrenochrome on the circulation
were also studied by Marquardt and Oettel (1948)
and Beau-Villain (1951).
Kuschinsky, Hille and Emmerich (1952a)showed
that adrenochrome liberates histamine. When the
hind limb of the mouse was perfused with adrenochrome
or its semicarbazone, adrenoxyl,there was an increase
of oedema as against the control. The outflowing
fluid contained histamine or a similar substance.
Both adrenochrome and adrenoxyl shortened the bleed¬
ing time of the rabbit and this action was prevented
by antihistamine. The bleeding time was similarly
shortened by histamine and prevented by antihistamines




Adrenochrome in a concentration of 100 mg/l.
caused contraction of guinea-pig's and rabbit's ileum
This response was not affected by atropine (10~)
-3
but was inhibited by antihistamines (10 ). The
uts of rats and golden hamsters were less sensitive
Adrenochrome, like histamine, increased the tone of
isolated arterial preparations (Kuschinsky, Hille and
Rmmerich, 1952b).
Adrenolutine
The name 'Adrenolutine' was suggested by
Lund (1949 ) for a yellowish-green fluorescent sub¬
stance formed by the oxidation of adrenaline in
I
alkaline solution. It was proved to be l-methyl-5,
6-dihydroxy-indoxyl by the above worker.
This substance is the fluorescent product of
adrenaline, on the formation of which, the fluori-
metric determination of adrenaline is based (Lund,
1949 ). It is very unstable. The pharmacological
actions of this substance are unknown.
5-Hydroxytryptamine (HT)
The interest in the pharmacological study
of indole compounds was re-awakened when the vaso¬
constrictor principle present in beef serum was identi
fied by the work of Rapport (1949) as 5-hydroxytrypta
mine. Rapport, Green and Page (1948a) called it
serotonin/
25.
serotonin and showed that it Is present in extracts
of serum and that It had a powerful constrictor action
on the perfused ear of a rabbit.
The name 'enteramine' was given by Erspamer
(1940) to an unidentified smooth muscle stimulating
substance present in acetone extracts of gastro¬
intestinal mucosa. He obtained evidence that it was
present in acetone and alcohol extracts of the
posterior salivary glands of octopoda (Erspamer, 1940,
1948a; Erspamer and Asero, 1953).
The enteramine-like substance appears in the
■ '' ■ "
salivary extracts in two forms: A itself active and I
Itself inactive but easily activated, i.e., trans¬
formed into A by simple treatment at pH6-9. Only
form A can be directly attacked by enteraminase;
I jfh !'• " f J'" " * ' { 1 Y ' \ . j • J
form I can be only after activation. The fresh
' ' ' "' !■ -J ■
material contains much more substance than stale.
It was also shown to be present in mammalian
spleen (Vialli and Erspamer, 1942; Erspamer, 1943a);
in the hypobronchlal body of murlcidia (Erspamer,
1948b)and in amphibian skin (Erspamer and Vialli,
1951, 1952). The presence of enteramine was
demonstrated by the above authors by means of colour
reactions, pharmacological reactions and by the method
of chromatography on paper.
Erspamer/
26.
Erspamer and Paustlni (1953) also found entera-
mlne in the serum of vertebrates and in the haemo-
lymph of octopoda.
More recently, enteramine was identified as
5-hydroxytryptamine (Erspamer and Boretti, 1951;
Erspamer and Asero, 1952). It seems possible that
5-hydroxytryptamine is also the active substance of
the serum vasoconstrictor agent described by Preund
(1920) as "Spatgift" and as "Thrombocytin" by Reid
(1943). Recently, Quick (1950) suggested a com¬
promise name "Thrombotonin".
It has also been synthesised (Hamlin and Fischer,
1951} Speeter, Heinzelmann and Weisblatt, 1951;
Erspamer and Asero, 1952} Asero, Colo, Erspamer and
Vercellone, 1952).
Amin, Crawford and Gaddum (1952) presented
evidence that 5-hydroxytryptamine is present in cer¬
tain parts of the brain.
Dalgleish, Toh and Work (1952, 1953) by sub¬
mitting the acetone extracts of small intestine to
counter current fractionation and assaying the
fractions on the rat»s atropinised colon showed that
there were two active principles. One of these active
principles was identified as 5-hydroxytryptamine by
means/
27.
means of paper chromatography and was distinguished
from substance P.
Feldberg and Toh (1953) and Erspamer (1953b,c)
studied the distribution of 5-hydroxytryptamine in
the wall of the digestive tract.
Twarog and Page (1953) showed that 5-hydroxy-
tryptamine occurs in acetone extracts of dog, cat and
rabbit brain in amounts ranging from 0.1 - 0.36 pg/g
tissue, and that it is normally excreted in human and
dog urine in amounts varying between 0.1 - 1.0 jig/ml.
The assay was done on the Isolated heart of the
mollusc venus mercenaria supported by unl-dimension-
al paper chromatography.
Holgate (1953) found 5-hydroxytryptamine in
heparinised blood but not in citrated blood of the
rabbit.
Bacq, Fischer and Ghlretti (1952) and Ghiretti
(1953) reported the release of 5-hydroxytryptamine
by the stimulation of nerves to salivary glands.
Humphrey and Jaques (1953) demonstrated the release
of a substance with serotonin-like activity in vitro
by antigen-antibody reaction. The assay was carried
out on rats' colon and atropinised rats' uterus and
the/
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the identification was based upon specific inhibition
by tryptamine and 2-methyl-3-ethyl-5-amlno Indole.
'; . , . ; ....
5-hydroxytryptamine has been identified in wasp
venom by paper chromatography and the specific elute
found to be pharmacologically identical with this
substance (Jaques and Echachter, 1954). Erspamer
and i>ala (1954) have reported the identification of
the stable antidiuretic substance ("Stable ADS") of
serum (Glnsburg and Heller, 1951, 1953; Heller, 1952)
with 5-hydroxytryptamine.
Taylor, Page and Corcoran (1951) made experiments
with cross circulation in dogs and stimulated the vagus
centrally. They then detected the release of a sub¬
stance from the brain, the properties of which
appeared to be like those of 5-hydroxytryptamine.
This evidence was criticised by Erspamer (1952a) as
non-specific.
Recently, Lembeck (1953) has obtained large
quantities of 5-hydroxytryptamine in carcinoids,
(5 mg per gram of tissue).
Undenfriend, Clark and Titus (1952, 1953)
reported the presence of 5-hydroxytryptamine and
5-hydroxytryptophan in the venom of toads (bufo-
marinus). The above authors showed the presence
in/
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in animal kidney extracts of a specific de-carboxy-
lase which converts 5«hydroxytryptophan to 5-hydroxy-
tryptamine and produced direct evidence that hydroxy-
lation of the 5 position is a normal pathway in
tryptophan metabolism. They also suggested that the
presence of methylated derivatives in the toads and
other animals may be evidence of a pathway for the
metabolism of 5-hydroxytryptamlne.
Erspamer and Boretti (1950) identified entera-
mine by paper chromatography. A fluorescene test
for 5-hydroxytryptamine has also been reported
(Shepherd West and Erspamer, 1953; Jepson and Stevens,
1953). Barter and Everson Pearse (1953) detected
5-hydroxytryptamine in mammalian entero-chromaffine
cells by histochemical and histophysical methods.
Enteramine has a powerful stimulant action on
the isolated atroplni83d oestrous uterus of rats and
mioe, the duodenum of the rat, the urinary bladder
of the dog, both in vivo and vitro (Erspamer, 1940)
and the heart of a mollusc (Erspamer and Ghiretti,1951).
The isolated heart of a mollusc (venus mercenaria)
was found to provide a selective and very sensitive
method for estimating 5-hydroxytryptamine (Twarog and
Page, 1953; Welsh, 1953). 5-hydroxytryptamlne
increased/
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increased the amplitude of the beat in a concen-
"9 "8
tration of 10 to 10 , and the effect was immedi¬
ately reversible. The same authors observed that
anterior byssus retractor muscle of Mytilus edulis,
an edible mussel, was relaxed by 5-hydroxytryptamine.
It was found to have an antidiuretic effect in
hydrated rats and dogs (Erspamer and Ottolenghi,
1951; Barac, 1953). Erspamer (1952a) showed that
enteramine antidiuresis was due to a reduction of
the glomerular filtration rate, as a consequence of
a fall in intraglomerular hydrostatic pressure.
This fall in turn was caused by an increase in tone
or a spasm of the contractile structures of the
afferent vascular bed of the glomerulus. He
suggests that enteramine, the specific storage or
secretion product of the entero-chromaffine cell
system, may be considered as a true hormone whose
task is to control in the rat, and presumably in
other vertebrates, the tonus of the afferent
vascular bed of the glomerulus and therefore the
intra-renal circulatory dynamics (Erspamer and
Ottolenghi, 1953). Sala and Castegnaro (1953)
carried out numerous researches on the effect of
enteramine on the renal function and circulation of
the dog. They emphasised that the anti-diuretic
action of enteramine, in this experimental animal
was/
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was due to stimulation of tubular re-absorptive
activity and minimised the role of constriction of
the afferent vascular bed of the glomerulus. The
mechanism of the anti-diuretic action in physio¬
logical doses of enteramine therefore, may be
different according to the animal species and perhaps
to other conditions.
The pharmacological and physiological actions
of enteramine have been extensively studied on various
tissues (Erspamer, 1942b, 1943b,1952b, 1953d, 19535,
and Erspamer and Asero, 1951).
The blood pressure of atropinised rabbits and
cats was suppressed by enteramine (Erspamer and
Ottolenghi, 1950, 1952). Freyburger, Graham, happort,
^eay, Govier, Ewoap and Vander Brook (1952) reported
variable effects on the blood pressure of dogs and
cats. Erspamer (1952a) and Page and McCubbin (1953a)
explained that enteramine was by no means a pure
hypertensive substance in as much as it may possess,
according to circumstances hypertensive, hypotensive
and biphasic actions.
Page and McCubbin (1953a) coined a new term




Keid and Hand (1951) showed that 5-hydroxy-
tryptamine on Intravenous injection in the cat caused
a rise in pressure in the pulmonary artery and a rise
of systemic arterial pressure, which may be preceded
or followed by a fall. This fall of blood pressure
was due to the constriction of the pulmonary vascular
bed.
5-hydroxytryptamine constricts the vessels of
the hind limb and kidney of the cat, and contracts
the isolated carotid artery of the sheep, dog and ox.
It liberates adrenaline from the adrenal medulla of
the cat and also causes bronchoconstriction and
respiratory arrythmia in the cat (Eeid and Rand,
1951). Gaddum, Hebb, Silver and Swan (1953) con-
✓
firmed the evidence that 5-hydroxytryptamine caused
vasoconstriction and bronchoconstriction in cats'
lungs perfused with blood.
Douglas and Toh (1952, 1953) found that 5-
..
hydroxytryptamine was a respiratory stimulant in the
dog and exerted this effect in several ways which
included stimulation of the afferents in the vagus.
Schneider and Yonkman (1953) also studied the
influence of 5-hydroxytryptamine on vagal afferents
impulses in the cat.
The/
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The effect of 5-hydroxytryptamlne on the circu¬
lation and respiration was studied by other workers.
(Page, 1952a,c; Held, 1952J Comroe, 1952J Mott and
Paintal, 1953; Heymans and Heuvel-Heymans, 1953).
The pharmacological actions of synthetic 5-hydroxy-
tryptamine have been studied by various workers (Held
and Hand, 1951, 1952; Freyburger et al,1952; Page, 1952a;
Erspamer, 1952a, 1953a; Erspamer and Ottolenghi, 1953;
0-addum, 1953a). They have a quantitative resemblance
to those of tryptamine (Laidlaw, 1912; Held, 1951).
It potentiates the action of adrenaline on nictitating
membrane and blood pressure of the cat (Lecomte.1953).
Carrel, Lyth, Long and Vanderpoel (1952) studied
the haemostatic effect of 5-hydroxytryptamine in rats,
guinea-pigs, chiokens and rabbits and concluded that
it had a marked haemostatic activity but the effect
was very short-lived. Page (1952b) also suggested
that it had a haemostatic property.
Armstrong, Fry, Keele and Markham (1952)
observed a painful reaction after the application of
-s
5-hydroxytryptamine in a concentration of 10 to the
site of a blister Induced in the skin by cantharldesj
Umrath (1953) observed no pain in the cornea when a
concentration of 10"® was applied.
Feldberg/
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Feldberg and cmith( 1953a,b) showed the release
of histamine by 5-hydroxytryptamlne and tryptamine
in the cat, the dog and the rat. The histamine
releasing activity of these compounds is somewhat
greater than that of propamidine and less than that
of 48/80.
Rapport and Virno (1952) found that 5-hydroxy-
tryptamine depressed the rate of oxygen consumption
in albino rats when injected intraperltoneally
(1 mg/kg). This was not noticed in the rabbit,
guinea-pig or dog. Rats were particularly suscept¬
ible and showed temporary fore- and hind leg paralysis
and narcotic effects. Feldberg and Sherwood (1953,
1954) injected 5-hydroxytryptamine into the ventricle
of the brain in the cat and found that 10 pg of 5-
hydroxytryptamine had no effect, but 100-200 pg
produced licking, profuse salivation, retching,
tachypnoea, catatonia and muscular weakness. The cat
was not sleepy or drowsy.
Florey and Florey (1953) showed that 5-hydroxy-




Reid and Hand (1951) reported that yohimbine
inhibits the pressor action of 5-hydroxytryptamine a
well as its stimulant effect on an isolated piece of
carotid artery. The pressor action of 5-hydroxy¬
tryptamine was also inhibited by 1-hydrazino-
phthalazine (c - 5968) (Taylor, Page and Corcoran,
1951), but Erapamer (1952a) reported a non-specific
effect with this drug. The modification of the
vascular response to 5-hydroxytryptamine by a large
number of drugs was extensively studied by Page and
McCubbin (1953b).
McCawley, Leveque and Dick (1952) observed sinus
tachycardia in anaesthetised dogs after the admini¬
stration of 5-hydroxytryptamine which was abolished
by Apresoline (l-hydrazino~phthalazine c-5968) or
veriloid but not with atropine or N-ethyl-K-l-naphthy
methyl-2-bromo-ethylamine (SY - 28).
Woolley and Shaw (1952, 1953c) studied some
related anti-5-hydroxytryptamine compounds and found
that 2-methyl-3-ethy1-5-amino indole was an antagonis
of 5-hydroxytryptamine when tested on isolated ring-
shaped pieces of sheeps carotid artery. The
corresponding nitro compound when fed to dogs,
abolished/
36.
abolished the rise in blood pressure which followed
the intravenous injection of 5-hydroxytryptamine
but did not affect that due to adrenaline (Woolley
and bhaw, 1953a).
Spies and Stone (1952) could not demonstrate
any change in the blood pressure of patients with
hypertension after 300 mg of 2-methy1-3-ethy1-5-amino
indole had been given intravenously over a period of
eight hours for 2-3 days or after the oral admini¬
stration of 22 g for eight days. Page and McCubbin,
(1953b) also failed to show any effect with this
drug in hypertensive patients. No toxic effects
were observed. Iverson and Bull (1953) gave
2:3 dimethyl-5-amino indole to hypertensive subjects
with no effect.
Yohimbine and ergotoxinehave been reported as
naturally occurring anti-metabolites of 5-hydroxy-
tryptamine (Woolley ahd Shaw, 1953b). Dihydro-
ergotamlne and dibenanaine have been found powerful
antagonists to 5-hydroxytryptamine in its action on
rats' uterus and in its anti-diuretic effect
(trspamer, 1952b; Fingl and Gaddum 1953). Lysergic
acid diethylamide (LSD) has been reported to be an
extremely potent anti-5-hydroxytryptamine compound
on/
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on the isolated rat uterus (Gaddum, 1953b).
Antihistamines do not have a marked anti-5-
hydroxytryptamine effect (Erspamer, 1952b; Rapport
and Koelle, 1953; Herxheimer, 1953a).
Sinha and West (1953) showed on several isolated
organs that various local anaesthetics inhibited the
response to 5-hydroxytrytamine and their potencies
corresponded to their local anaesthetic activity.
Atropine (0.32 mg/kg) gives considerable but
incomplete protection against 5-hydroxytryptamine-
induced bronchial spasm in guinea-pigs (Herxheimer,
1953a, 1953b). Atropine (10 ng-100 p.g per 1.)
inhibits the effect of 5-hydroxytryptamine on iso¬
lated guinea-pig ileum (Rapport and Koelle, 1953;
Robertson, 1953 and Rocha e Eilva, Valle and
Picarelli, 1953). Robertson (1953) and Rocha e
Eilva et al (1953) also found that hexamethonium had
no action on the effect of 5-hydroxytryptamine on
guinea-pig's ileum and suggested that the drug acts
on the post-ganglionic para-sympathetic fibres.
Evans and Echild (1953) found that 5-hydroxy¬
tryptamine produced powerful rhythmic contractions
of/
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of the amniotic membrane of 10-12 days incubated
chicks. Since the amnion is knov/n to contain plain
muscle entirely devoid of ganglion cells and nerve
fibres, the action of 5-hydroxytryptamine cannot be
due to the release of acetylcholine from nerve end¬
ings but is probably a direct action on plain muscle.
Kapport et al. (1948b) reported the presence of
an enzyme in extracts of beef and dog lungs which
inactivated 5-hydroxytryptamine. Bradley, Butter-
worth, Reid and Traunter (1950) attempted to char¬
acterise the nature of this enzyme and suggested that
5-hydroxytryptamine is oxidised by a mono-amins
oxidase in the lung preparation through the same
mechanism as that suggested for tryptamine and
tyramine, That 5-hydroxytryptamine is rapidly
inactivated by amine oxidase has been reported by
Preyburger et al.(1952); Blaschko (1952a, 1952b) and
Blaschko and Philpot (1953). Blaschko and Hellmann
(1953) showed that tissues containing amine oxidase





In the experimental investigations reported
hereafter the doses of the following drugs are
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The doses of all the other compounds are quoted
in terms of the free base, acid or ester.
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Experimental Methods
Isolated oestrous uterus of the rat. This
organ was used by Erspamer (1940) as a test object
for the detection of enteramine (5-hydroxytryptamlne)
in tissue extracts. The uterus was suspended in
Tyrode solution at 37°C. in 7-8 ml bath. It is
difficult to understand why the drug was allowed to
act for 150 seconds before washing out, even though
a maximum contraction was obtained after about 40
seconds. Erspamer reported frequent spontaneous
activity of the preparation.
Erspamer (1942a, 195£b) used ovariectomized
rats, and brought them in oestrous by injecting
50-100 lig oestradlol propionate. A simple method
which eliminated the need for ovariectomizing the
animals was described by Amin, Crawford and Gaddum
(1952). A virgin rat of 160-200 g weight was
injected/
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Injected with 10 H€ of stilboestrol in 0.1 ml
arachis oil per 100 g body weight subcutaneously,
and the uterus was used the following day, 20-24
hours after injection of the rat.
The rat was killed by a blow on the head and the
uterine horns dissected out. After removing the
adherent adipose tissue, a piece of the uterus,
about 2 cm long from the middle portion of one horn
was tied off at either end and suspended in a 2 ml
bath at 30°C. The solution was that formulated by
de Jalon and recommended by Gaddum, Peart and Vogt,
(1949). It has the following composition (g/l.):
Nad, 9; KC1, 0.42; CaCla, 0.06;
NaHC03, 0.5; glucose, 0.5.
Use of this solution with reduced calcium ion
and glucose concentration and maintenance of the bath
temperature at 30°C. minimized the appearance of
spontaneous contractions. It was oxygenated by
bubbling through compressed air at a moderate speed.
The contractions were recorded with a light frontal
writing lever on a smoked drum with a magnification
of about 5. The tension on the tissue was of the
order of 815 mg. The experiment was started after
the/
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the uterus relaxed to its fullest extent, which
took 30 minutes after it was set up. When a dose
of 5-hydroxytryptamine of the order of 10-20 ng
was added to the bath a good contraction usually
occurred. A delay of 15 to 20 seconds between
the addition of the drug and the start of the
contraction of the uterus was frequently observed.
The contraction was usually completed within 45
seconds after the addition of 5-hydroxytryptamine,
and at this time the drug solution was washed out
and replaced by fresh de Jalon's solution.
Occasionally, the contraction of the uterus required
50 to 60 seconds to reach completion in which case
the bath fluid was changed one minute after the
addition of the drug. The muscle relaxed to its
original length rapidly after the drug had been
removed from the bath.
an interval of 4 minutes between doses was
usually found suitable. Occasionally, 5 minutes
interval between doses was found necessary when the
preparation/
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preparation showed tachyphylaxis with the 4 minute
interval.
An occasional uterine atrip showed marked
sensitivity to 5-hydroxytryptamine, an all or none
type of response being obtained with doses in the
region of 5 ng of 5-hydroxytryptamine. The
sensitivity of these preparations was reduced to
the normal level by increasing the load on the
muscle. The non-oestrous uterus is 10-50 times
less sensitive to 5-hydroxytryptamine.
Isolated rat duodenum. Erspamer (1940)
described this preparation for testing enteramine-
eontaining tissue extracts. It was suspended in
a 2 ml bath containing Tyrode's solution at 37°C.
It proved rather insensitive to 5-hydroxytryptamine
A dose of 1 pg of 5-hydroxytryptamlne did not give
a good response whereas 1 pg of carbachol produced
a good contraction. This preparation, therefore,
was not considered suitable for testing 5-hydroxy¬
tryptamine .
Isolated rat colon. This tissue has been used
by Peldberg and Toh (1953) for the assay of entera-
mine/
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enteramlne activity. Rat colon (portion adjacent
to caecum) was set up in a 2 ml bath in Locke's
solution as modified by Gaddum, Peart and Vogt (1949).
The temperature of the bath was kept at 22°C. In
comparison with the rat's oestrous uterus, the colon
preparation proved much less sensitive. A dose of
10 pg 5-hydroxytryptamine in a 2 ml bath produced a
small contraction whereas 0,5 pg carbachol gave a
marked response. Freyburger et al (1952) also found
this preparation less sensitive to 5-hydroxytrypta-
mine.
Isolated guinea-pig's ileum. Guinea-pigs
weighing 200-250 g were killed by a blow on the head.
The portion of the ileum nearest the caecum was
removed and cleaned out with Tyrode's solution
introduced into the lumen by means of a pipette. A
piece about 2 cm in length was suspended in a 2 ml
bath containing Tyrode solution maintained at 37°C
through which compressed air was bubbled at a moder¬
ate rate. The suspended piece of intestine was
threaded with two loops at each end so that the lumen
of the intestine remained open. The movements of the
gut were recorded with a light frontal-writing lever
on a smoked drum with a magnification of 5.
A/
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A dose of the order of 50-100 ng of 5-hydroxy-
tryptamlne usually gives a satisfactory contraction.
_ome pieces of ileum removed from a guinea-pig which
had been starved a day earlier and set up without any
traima were sensitive to 10-20 ng of 5-hydroxy-
tryptamlne. It was also observed that strips of
gut which had been kept in Tyrode solution and used
a few hours after killing of the animal were less
sensitive.
Robertson (1953) reported good contractions of
the guinea-pig's ileum with a dose of 2 ng of
5-hydroxytryptamine which were equivalent to those
produced by a dose of 4 ng of acetylcholine.
5-hydroxytryptamine was allowed to act for 40
seconds and the time Interval between the doses was
3-4 minutes. There was immediate relaxation of the
muscle after the drug had been removed from the bath.
On rare occasions, tachyphylaxis to the drug
was noted, although Reid and Rand (1952) and Sinha
and West (1953) reported this phenomenon more
frequently. The preparation gives fairly constant
responses,/
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responses, but the dose response curve is not as
steep as with rat uterus. In general, it proved to
be less sensitive than the rat uterus preparation.
Various workers (Gaddum, 1953a; Rapport and Koelle ,
»
1953; Rocha e Silva, Valle and Picarelll. 1953) have
used this tissue for experiments with 5-hydroxy-
tryptamine.
Isolated guinea-pie's Jejunum and duodenum.
These preparations were set up as descri¬
bed for guinea pig's ileum.
The guinea pig's jejunum was used by Reid and
Rand (1952) as one of the test objects for studying
the effects of 5-hydroxytryptamine. It is ten times
less sensitive than guinea-pig»s ileum. A dose of
1 pg of 5-hydroxytryptamine produced a good response.
The guinea-pig's duodenum was insensitive. A
dose of 1 pg of 5-hydroxytryptamine gave a small
response. The preparation was also not very sensi¬
tive to histamine.
The jejunum and duodenum, on account of their
relative insensitivity, were not considered suitable
for experiments with 5-hydroxytryptamine.
Isolated/
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Isolated uterus of the guinea-pig. Both
oestrous and non-oestrous uteri were tested. The
'
procedure followed was as described for rat uterus
except that the bath contained Dale's solution at
37° C.
The contractions of the uterus (non-oestrous)
I
, • . , ;• • v.'
produced with 5-hydroxytryptamine were very irregular
and were characterised by a latency of 45-50 seconds.
A dose of 20 {xg of 5-hydroxytryptamine in a 2 ml. bath
produced a good contraction which was equal to a con¬
traction caused by 0.01 jxg of histamine. The
relaxation of the uterine muscle was slow after the
drug had been removed from the bath. Occasionally,
the preparation gave spontaneous muscular contractions
after the drug had been washed out.
On the basis of some of the above observations,
Reid and Rand (1951) concluded that the preparation
was unsuitable for assay of serum vasoconstrictor.
Freyburger at al(1952) also found that the responses




Oestrous uterus of guinea-pig. The uterus was
brought in oestrous by the injection of stilboestrol
as recommended for the rat uterus.
It/
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It was found very insensitive to 5-hydroxy-
tryptamine. Even histamine was not active on this
preparation.
Perfused rabbit ear. Perfusion of the iso¬
lated rabbit's ear was used by Rapport, Green and
Page (1948c) for the study of serotonin. Pingl and
Gaddum (1953) also used this preparation for testing
some of the actions of 5-hydroxytryptamine.
A rabbit was killed by a blow at the back of
the neck (not near the base of the ears on the head)
and its throat was cut. The ears were severed from
the head with a sharp scalpel. The central artery
on the dorsal surface of the ear was carefully
dissected out and held steady with a piece of thread
tied to the end. A small polythene cannula was
inserted into the artery and connected to a rubber-
capped injection cannula as described by Gaddum and
Kwiatkowskl (1938). The injection cannula was
connected to two perfusion reservoirs, one containing
the ordinary perfusion solution and the other con¬
taining the antagonist drug. The ear was placed on
a draining plate and secured with a pin and the per¬
fusate from the cut surface was led to a small
collecting funnel which ended into a horizontal
capillary/
Figure 1
Apparatus for perfusion of the
Isolated ear of a rabbit.
47.
capillary tube. The capillary end of the collecting
funnel was connected to a drop-timer (Gaddum and
Kwiatkowskl, 1938). The apparatus is illustrated
in Fig. 1).
The ear was perfused at room temperature.
Mariotte bottles were avoided as they were liable
to introduce irregularities in the flow associated
with the escape of each bubble (Gaddum, 1950). The
composition of the perfusion fluid was important. It





MgCl3. 6Hs0 0.06 g/l
KaHCOs 0.4 g/l.
Glucose 1.0 g/l.
To this is added 10 ml. of phosphate buffer
containing 4 parts of 1M Ks HPQ«, to 1 part of 1M
KHaP04.
When this solution was used, the ear was much
more sensitive to vasoconstrictor substances than
when Locke's solution was used.
The/
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The ear was perfused under pressure (approxi¬
mately 35 cm. saline) until blood was no longer
evident in the perfusate. The height of the
reservoir was then adjusted so that the drop rate
of the effluent was 60-70 per minute. This
pressure was then kept constant throughout the
experiment. A wooden meter rule was fixed to the
apparatus to control the pressure.
After the ear had been perfused for an hour,
responses to the test agents were elicited. The
ear was always more sensitive on the next day after
being kept overnight in the refrigerator. It had
been observed that the ear could work satisfactorily
for three days if kept in proper condition.
The record of the outflow is a series of
vertical lines and the height of each line is a
measure of the time interval between drops. When
a vasoconstrictor substance such as 5-hydroxytrypta-
mlne or adrenaline was injected, the heights of the
lines/
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lines increased owing to lengthening of the
intervals between drops of the effluent. Further
injections were made when :ne outflow returned to
normal.
A dose of 1-10 ng of 5-hydroxytryptamine
usually gave a good response. An occasional
preparation showed marked sensitivity, a good
response being obtained with doses as low as 0.5 ng
of 5-hydroxytryptamine and adrenaline. In com¬
parison with adrenaline, the response to 5-hydroxy-
tryptamine was characterised by a latency of a few
seconds and of more prolonged vasoconstriction.
Isolated rabbit duodenum.
Fingl and Gaddum (1953) tested the
activity of ergot alkaloids to block the contractions
of 5-hydroxytryptamine on the rabbit's duodenum,
A rabbit was killed by heavy blows on the neck
and its throat was cut. A piece of duodenum
adjacent to the pylorus was removed and the content
of/
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of the lumen washed out by running In Locke solution
from a pipette. Care was taken to avoid excessive
trauma. A short segment, about 3 cm long was sua-
pended In a 13 ml,bath containing Locke solution
maintained at 37°C. and through which air was
bubbled at a moderate rate. In most experiments,
segments were weighted sufficiently to prevent
changes in tone.
After the muscle had been suspended in the bath
for one hour, drugs were applied at 5 minutes interva
and contractions recorded on a smoked drum. A dose
of 10 pg of 5-hydroxytryptamine in a 13 ml,bath gave
a good response. The preparation was not very
sensitive and frequently showed marked spontaneous
activity.
Rabbit Jejunum. Reid and Rand (1952) reported
the stimulant effect of 5-hydroxytryptamine on rabbit
jejunum. The details of setting up the preparation
were the same as described for rabbit's duodenum.
It was less sensitive than rabbit's duodenum;
a dose of 30 pg 5-hydroxytryptamine in a 13 ml.bath




Isolated rabbit uterus. Freyburger et al.(l952!
found that 5-hydroxytryptamine was about l/40 as
active as ergonovine maleate on non-pregnant isolated
rabbit's uterus.
Non-oestrous and oestrous uteri were tested.
Non-oestrous uterus. A small strip of one
horn was suspended in a 2 ml.bath containing Locke's
solution maintained at 37°C.
A dose of 10 pg 5-hydroxytryptamine in the 2 ml,
bath gave a good contraction, but the response to
subsequent doses was reduced. Adrenaline in a
concentration of 0.1 pg/ml.produced a satisfactory
response.
Osstrous uterus. The uterus was brought in
oestrous by the injection of 100 mg/kg of stil-
boestrol. The injections of stilboestrol were given
subcutaneously for two consecutive days and the animal
was killed on the third day. A piece of a uterine
horn was suspended In a 2 miL bath containing Locke's
solution maintained at 37°C.
The preparation gave marked spontaneous activity.
The temperature was lowered to 30°C. but the spon¬
taneous activity persisted.
De Jalon's solution, as recommended for rat's
uterus, was substituted in place of Locke's solution.
It/
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It reduced the spontaneous activity. A dose of
1 |ig of adrenaline in the 2 ml bath gave a good
contraction, but 5-hydroxytryptamine in a dose of
50 ng was without much effect.
Isolated rabbit's uterus, was thus not a
suitable tissue for experiments with 5-hydroxy¬
tryptamine .
5-hydroxytryptamine was found to cause
contraction of the uterus, duodenum and colon of
rats, duodenum and jejunum of rabbits, and the uterus,
duodenum, jejunum and ileum of guinea-pigs and vaso¬
constriction in the perfused rabbit's ear.
The most sensitive of these tissues were the
rat's uterus (Erspamer, 1952a); the guinea-pig's
Ileum (Gaddum, 1953a; Robertson, 1953; Kocha e Silva,
Valle and Plcarelli, 1953) and the rabbit's ear
(Rapport, Green and Page, 1948c),all of which have
been used before for experiments with 5-hydroxy¬
tryptamine. These three sensitive tissues have been




DRUGS WHICH AHTAGOHISE 5-HXDROXTTRYPTAMINE.
52.
Drug a which antagonise 5-hydroxytryptamine.
There Is some evidence that some of the
actions of 5-hydroxytryptamine (HT) and tryptamine
are due to combination with special receptors, which
are not identical with the receptors for histamine,
adrenaline or acetylcholine and which have been
called tryptamine receptors (Gaddum, 1953a). These
other drugs all have effects like those of HT on some
tissues but not on all tissues. Histamine and
adrenaline do not stimulate rat's uterus; adrenaline
does not stimulate guinea-pig's ileum and acetyl¬
choline causes vasodilatation rather than vaso¬
constriction in the freshly prepared rabbit's ear
(Burn and Robinson, 1951).
In every case, a test of specificity was
carried out by comparing the effect of HT with that
of a suitable dose of some other drug before and
after the addition of the antagonist. When the
effects of both drugs were depressed the antagonism
was considered unspecific and unimportant. Such
effects may be caused by depression or poisoning of
the/
Figure 2
HT T C T HT T C C HT T C HT T
HYDROXYTRYPTAMINE — 30/10.
TIME (min.)
O 4 8 12 16 29 42 55 59 63 67 71 75
Rat's uterus - 2 ml. bath
HT - 5-hydroxytryptamine 150 ng
T - tryptamine 15000 ng
C - carbachol 1500 ng
16-56 min. a high concentration
of HT (15000 jxg/l. ) abolished the
responses to tryptamine and HT but
not that to carbachol. On removing
HT from the bath, tryptamine caused
a response after 15 min.
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the contractile mechanism. The statement that an
antagonism was specific means that the effect of
5-hydroxytryptamine was depressed while the effect of
the control drug was not. This test does not prove
that 5-hydroxytryptamine and its antagonist are com¬
peting for the same receptor, but does exclude some
cases in which they are not. The usual control
drugs were acetylcholine for rat's uterus, histamine
for guinea-pig's ileum and adrenaline for rabbit's
ear.
Tachyphylaxis. Guinea-pig's ileum can be
specifically desensitized to 5-hydroxytryptamine by
exposure to high concentrations of this drug or
tryptamine (Gaddum, 1953aj Rocha e Silva et al.1953).
Similar results may sometimes be obtained with
the rat's uterus. In one experiment, (Pig. 2),
5-hydroxytryptamine (75 p.g/1.) and tryptamlne
(7500 P^g/l. ) caused effects similar to those of
oarbachol (750 ng/l.). A high concentration of 5-
hydroxytryptamlne (15,000 pg/l.) was added to the
bath for 43 minutes. This caused strong contractions
which disappeared after 13 minutes. The muscle now
gave no response to 5-hydroxytryptamine or tryptamine,
but the effect of carbachol was unchanged. This
desensitization/
Figure 5
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GRAMINE
Hat's uterus - 2 ml* bath - interval 3 min.
HT - 5-hydroxytryptamine 20 ng
C - carbaehol 100 ng




desensitization persisted for 15 minutes after the
high concentration of 5-hydroxytryptamine had been
i
removed; the muscle then again gave a response to
tryptamine. In sortie experiments, the effect was
obscured by the persistence of muscular contraction
in the presence of 5-hydroxytryptamine, or tryptaminC.
The inhibitory effects of high concentrations of 5-
hydroxytryptamine or tryptamine were much less
clearly shown on the rat's uterus than on the guinea-
pig's ileum. It would not be easy to do similar
experiments with the rabbit's ear because large
doses of 5-hydroxytryptamine stop the flow completely.
Specific antagonisms are commonly due to the
competitive action of drugs similar in structure to
the active drug and tests have therefore been made
with & number of compounds which, like 5-hydroxy¬
tryptamine, contain an indole nucleus. Most of
these were specially prepared by Messrs. Glaxo Labs,
and the results will be described in subsequent study,
Section IV).
Gramine (3-dimethyl amino methyl-indole) acted
as the prototype for a number of active synthetic
anti-5-hydroxytryptamlne compounds and its effect on
the/
Figure 4.




From 9.18 gramine (10 mg/l.) was
continuously present in the perfusion
fluid. Both drugs antagonised, but
HT more than adrenaline.
55.
the rat's uterus Is shown in Fig. 3. It abolished
the response to 5-hydroxytryptamine without affecting
the response to carbachol. The effect immediately
recovered after the drug was washed out. Erspamer
(1954) has observed the same effect. A concen¬
tration of less than 10 mg/l, of gramine did not
inhibit the 5-hydroxytryptamine response to a marked
extent. It is liable to produce muscular contrac¬
tions especially If kept for more than 10 minutes in
the bath. Higher concentrations of the drug caused
contractions and the uterus started spontaneous
activity after the drug had been removed from the
bath. In a concentration of 10 mg/l. it decreased
the sensitivity of the rabbit's ear to 5-hydroxy¬
tryptamine by more than two-thousandfold and that to
adrenaline by about fifteenfold (Fig. 4). It
caused slight vasoconstriction of the rabbit's ear.
On guinea-pig's ileum, its action against 5-hydroxy-
tryptamine was feeble and non-specific. Histamine
was also markedly inhibited.
Eraot alkaloids. Tryptamine forms part of the
molecule of lysergic acid, certain derivatives of
which are very active antagonists of 5-hydroxy¬
tryptamine on the rat's uterus and the rabbit's ear.
The/
Figure 5
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amide (100 |ig/l«) specifi¬
cally inhibited the response
to HT.
56.
The antagonism of ergotoxine and tryptamine was
described by Laidlaw and that of ergotamine and a-
methyl tryptamine by £>ekl (1929).
Heymans, Bouckaert and Moraes (1932) found that
ergotamine antagonised the vasoconstrictor action of
defibrinated blood which was presumably due mainly
to 5-hydroxytryptamine, Gaddum, Peart and Vogt
(1949) obtained similar results with dihydroergotamlne
and made the additional observation that suitable
concentrations of this drug suppressed the response
of the rabbit's ear to cat's plasma without altering
the response to adrenaline. This fact seemed sur¬
prising at the time, but is now explained since the
response to 5-hydroxytryptamine can also be suppresse
without altering the response to adrenaline.
The antagonism of ergot alkaloids and 5-hydroxy
tryptamine has been studied more recently by Erspamer
(1952b), ohaw and Woolley (1953), Pingl and Gaddum
(1953) and Page and McCubbin (1953b).
Lysergic acid diethylamide (LSD) has been
reported by Gaddum (1953b) as the most active and
specific of these derivatives.










Rat's uterus - 2 ml. bath
HT - 5-hydroxytryptamine 14 ng
AC - acetylcholine 80 ng
T - tryptamine 1600 ng
DHE - dihydroergotamlne (50 M-g/l)
for 10 min and washed out.
The response to HT was
abolished, but that to
acetylcholine potentiated.
57.
the rat's uterus in which lysergic acid diethylamide
(100 pg/l.) inhibited the effect of 5-hydroxy-
tryptamine completely without affecting the response
to acetylcholine. When lysergic acid diethylamide
was left in the bath its activity continued to
increase and a dose of 30,000 ng of 5-hydroxy-
tryptamine did not give much effect after about an
hour.
Lysergic acid diethylamide in a concentration
of 10 Mg/l. or even less, completely inhibits the
effect of 5-hydroxytryptamine on rat's uterus.
Dihydroergotamine in a similar experiment
specifically inhibited the response to 5-hydroxy-
tryptamine (Pig. 6 ) and the effect continued to
increase with time.
Lysergic acid diethylamide and dihydroergotamin
in higher concentrations tend to cause contractions
of the uterus especially if kept for longer periods
in the bath.
A. series of derivatives of lysergic acid
have been tested for their effects on the rat's
uterus as antagonists of 5-hydroxytryptamine. Their
relative activities have been determined quanti¬
tatively and will be described under section IV.
They/
Figure 7
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Rat's uterus - 2 ml. bath
HT - 5-hydroxytryptamine 20 ng
AC - acetylcholine 200 ng
T - tryptamine 3000 ng
EM - ergometrine (500 Hg/l.) for
10 min and washed out.
Note the partial Inhibition of the
response to HT and the potentiation
of the response to acetylcholine.
The responses to both drugs subse¬
quently show a gradual return to
original levels.
58.
They are placed In the following descending order of




Ergotamine, ergotoxine and ergometrine generally
caused much spontaneous activity in the concentrations
used, but in all cases there was evidence of a fall
in the response to 5-hydroxytryptamine in conditions
where there was no change in the response to a choline
ester. However, those observations which could be
made, indicated that slightly higher concentrations
of ergotamine and ergotoxine as compared to dihydro-
ergotamine, were required to inhibit the effects of
5-hydroxytryptamine while ergometrine was the least
actlve.
Figure 7 shows that a concentration of 500pg/l
ergometrine produced contractions and rhythmic
activity of rat's uterus. It was kept in the bath
for 10 minutes and then vrnshed out. The subsequent
direct effects of 5-hydroxytryptamine and tryptamine
were only partially inhibited -while the effect of
acetylcholine was potentiated. Higher concen¬
trations (25 mg/l.) of ergometrine did not completely
abolish the response to 5-hydroxytryptamine and
tryptamine./
Figure 8
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Rabbit's ear perfused as In Fig. 4. Doses In ng.
HT - 5-hydroxytryptamine
AD - adrenaline
LSD - lysergic acid diethylamide
(10 y.g/1.) specifically
inhibited the response to HT.
59.
tryptamine.
It was frequently observed that ergot alkaloids,
especially dihydroergotamine, dihydroergokryptine,
ergotamine and ergometrine in low concentrations
potentiated the response of rat's uterus to acetyl¬
choline. This result confirms that of Dale (1906).
Dihydroergocristine caused marked Inhibition,
but this was not specific.
The results with dihydroergotamine confirm
those of Erspamer (1952b; 1953a) and^Pingl and
Gaddum (1953). m
Lysergic acid diethylamide, dihydroergotamine,
ergotamlne and ergometrine were also tested on the
rabbit's ear. With this tissue it is possible to
compare their actions against 5-hydroxytryptamine
J _ L~
and adrenaline, both of which cause vasoconstriction.
Whenever this comparison has been made, the response
to 5-hydroxytryptamine has been depressed more than
the response to adrenaline.
Figure 8 shows the results of an experiment
where 5-hydroxytryptamine (6 ng) had more vaso¬
constrictor action than adrenaline (1 ng). Lysergic
acid diethylamide was then perfused in a concentratio






FROM 3-25 ONWARD DiHYDROERGOTAMINE
20yug/l (2X IO-8) IN PERFUSED FLUID.
Rabbit's ear perfused as In Fig. 4.
Top tracing: Control doses of 5-hydroxytryptamlne
(3ng) and adrenaline (5ng).
Middle and
bottom tracing: Dlhydroergotamine antagonised both
drugs but 5-hydroxytryptamlne more than
adrenaline.
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of 5-hydroxytryptamine even when the dose was
increased to 2,000 ng. At the same time, the
response to adrenaline showed a gradual increase.
Again, when the ordinary solution was perfused for
, . ..
an hour, the response to 5-hydroxytryptamine returned
almost to its original value.
Figure 9 shows the results of a similar experi¬
ment with dihydroergotamine. A concentration of
20 M-g/l* of this drug abolished the response to
5-hydroxytryptamlne and greatly diminished that to
adrenaline, but when the doses were increased,
adrenaline was again effective. It was evident that
dihydroergotamine was more active as an antagonist
to 5-hydroxytryptamine than as an antagonist to
adrenaline, but its action was not so specific as
that of lysergic acid diethylamide. Again, a
slightly higher concentration of dihydroergotamine
was required to inhibit the effect of 5-hydroxy-
tryptamine.
In a concentration of 20 [ig/l. ergotamine did
not produce any significant inhibition of the response
to 5-hydroxytryptamine. In a concentration of
I • *
40 p.g/1. the responses to both 5-hydroxytryptamine
and adrenaline were abolished, but a 4-fold dose of
adrenaline was effective while a 100-fold dose of/
Figure 10
Rabbit1s ear perfused as in Fig. 4.
AD - adrenaline
HT - 5-hydroxytryptamlne
Ergot - Ergotamine (20 jxg/l.) had
no effect. In a higher concentration
(40 Hg/l.) ergotamine antagonised both
drugs, but HT more than adrenaline.
Figure 11
Guinea-pig's ileum - 2 mL bath
AC - acetylcholine 7 ng
HT - 5-hydroxytryptamlne 130 ng
M - mepyramine (100 tig//.)was present
in the Tyrode solution from 7 min.
LoD - lysergic acid diethylamide caused
partial inhibition of the response
to HT.
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of 5-hydroxytryptamine was not (Pig. 10).
The inhibitory activity of these ergot alka¬
loids on the rabbit's ear developed gradually and
continued to increase with time as in the experiments
with rat's uterus.
Ergometrine in a concentration of 20-100 ixg/l.
had no significant effect on the response to 5-
hydroxytryptamine or adrenaline.
All these ergot alkaloids produced slight vaso¬
constriction of the rabbit's ear in the concentration
used.
The antagonism between 5-hydroxytryptamine and
the ergot alkaloids on the guinea-pig's ileum is
comparatively feeble and less clearly specific. In
a concentration of 100 ng/l. lysergic acid diethyl¬
amide reduced the response to 5-hydroxytryptamine by
50 per cent but higher concentrations (10,000 pg/l. )
appeared to have no more effect (Pig. 11). The
response to histamine and acetylcholine were not
altered in these experiments. Lysergic acid
diethylamide in concentrations greater than 100 y.g/1.
and occasionally even at this concentration, produced
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Guinea-pig»s ileum - 2 ml. bath
Mepyramine 100 (ig/l* in Tyrode solution.
AC - acetylcholine 15 ng
HT - 5-hydroxytryptamine 150 ng
DHE - dihydroergotamine (5 mg/l. 10-25 min.
and 10 mg/l. 26-34 mln) inhibited
responses to HT and acetylcholine.
After dihydroergotamine was removed
from the bath the response to acetyl¬
choline recovered gradually to its
original level but there was slight
recovery of the response to HT
62.
If mepyramine in a concentration of 100 ust/l.
was present in the bath fluid, no such stimulation of
the gut was observed after higher doses of lysergic
acid diethylamide. It could be argued that lysergic
acid diethylamide liberates histamine in the guinea-
pig's gut which was the cause of stimulation. The
evidence for such an assumption is very meagre.
Low concentrations of dihydroergotamine had no
effect but when higher concentrations (2,500-25,000
|xg/l.) were used the response to 5-hydroxytryptamine
was depressed. In these conditions, the response to
histamine was also depressed, sometimes even more
than that to 5-hydroxytryptamine
Figure 12 shows that dihydroergotamine (5-lQmg/l.)
nearly completely blocked the response to 5-hydroxy¬
tryptamine and markedly inhibited the response to
acetylcholine. After the drug was washed out the
response to 5-hydroxytryptamine showed only partial
recovery while the response to acetylcholine
recovered completely. Mepyramine (lOO^g/l.) was
present In the Tyrode solution throughout the experi¬
ment .
Dihydroergotamine thus seemed to be less




Rabbit's duodenum - 13 ml. bath
AC - acetylcholine 1 y.g
AD - adrenaline 3 \ig
HT - 5-hydroxytryptamlne 10 pg
DHE - dihydroergotamine (3 s4mg/l.)
during time signal produced more inhibi¬
tion of the response to HT than of that
to acetylcholine. The response to
adrenaline was also inhibited.
63.
Dihydroergotamine inhibits the response of
rabbit's duodenum to 5-hydroxytryptamine. Figure 13
shows that dihydroergotamine in a concentration of
50 pg in a 13 ml bath produced about 39# inhibition
of the response to 5-hydroxytryptamine and 20#
inhibition of the response to acetylcholine.
Increasing the concentration of dihydroergotamine to
100 pg in the bath almost completely suppressed the
effect of 5-hydroxytryptamine, but the inhibition of
the response to acetylcholine remained about the
same (19#). When dihydroergotamine was removed,
both responses recovered. Thus the contractions of
the rabbit's duodenum induced by 5-hydroxytryptamine
were blocked by dihydroergotamine (Fingl and Gaddum,
1953) but the effect was not very specific.
Dihydroergotamine had no excitatory effects upon
the duodenum. There was no difference in the action
of dihydroergotamine in normal Locke's solution and
in Locke's solution containing reduced calcium and
glucose concentrations as employed for the experi¬
ments with the rat's uterus. The inhibitory
response to adrenaline seemed to be also suppressed
but Its extent could not be accurately judged as
there/
Figure 14
Rabbit's ear perfused as In Fig. 4.
AD - adrenaline
HT - 5-hydroxytryptamine
F933 - (Plperoxane) abolished
the response to adrenaline
without much effect on the
response to HT.
64.
there was a fall In the tone of the muscle after the
addition of dihydroergotamine in the bath.
Piperoxane (F933, piperldylmeth^lbenzodioxane)
Piperoxane is known as an antagonist of
adrenaline, but it had no significant antagonistic
action to 5-hydroxytryptamine in concentrations up
to 50 mg/l. on the rat's uterus (Fingl and Gaddum,
1953J Erspamer, 1953a). High concentrations
(25-50 mg/l.) of piperoxane caused the appearance of
rhythmic contractions which prevented observations.
However, in these experiments, no evidence of 5-
hydroxytryptamine blockade was apparent when
piperoxane had been removed from the bath after 10
minutes contact and rhythmic activity had ceased.
It had no anti-5-hydroxytryptamine effect on the
rabbit's ear (Fingl and Gaddum, 1953). Figure 14
shows the results of an experiment in which 5-hydroxy
tryptamine was first compared with adrenaline and
found to be 1.5 times as active. The perfusion fluid
was then replaced by a similar fluid containing
piperoxane (400 p.g/1.). This abolished the response
to adrenaline without any definite effect on the
response to 5-hydroxytryptamine. It is clear that
antagonism on the rabbit's ear to adrenaline and
Figure 15
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Rat's uterus - 2 ml. bath
HT - 5-hydroxytryptamlne
AC - acetylcholine
Dib.- dibenamlne (13 pg/1.)
specifically Inhibited
the response to HT.
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5-hydroxytryptamine may vary independently. Lysergi-1
acid diethylamide is more active against 5-hydroxy-
tryptamine and piperoxane is more active against
adrenaline.
Dibenamine (K,N-dibenzyl-f3-chloroethylamine) is
known as an antagonist of adrenaline with a very pro¬
longed action. It also has some antihistamine
activity (Nickerson, 1S49; Pleckenstein, 1952). It
antagonised the action of 5 -hydroxytryptamine on all
of the three tissues used in the present experiment.
Figure 15 shows the results of an experiment on
the rat's uterus in which dibenamine in a concen¬
tration of 15 Hg/l. abolished the effect of 5-hydroxy
tryptamine, even when the dose of 5-hydroxytryptamine
was increased to 1,000 ng, without affecting the
response to acetylcholine. Concentrations as low as
5 y.g/1. of dibenamine greatly reduced the response
of rat's uterus to 5-hydroxytryptamine. The effect
continued to increase for an hour or more* A concen¬
tration of 100 M-g/l. abolished the response to
5-hydroxytryptamine and slightly reduced that to
acetylcholine. The response to 5-hydroxytryptamine
was immediately, coupletely and irreversibly, blocked
The quantitative estimation of its anti-5-hydroxy-
tryptamine/
66.
tryptamine effect on rat's uterus will be discussed
under Seotion IV.
The receptors in the rabbit's ear were less
sensitive to dibenamine. A concentration of
100 y-g/l. caused 75$, inhibition of the response to
adrenaline and 64/6 inhibition of the response to
5-hydroxytryptamine. As in the case of the rat's
uterus, the block developed gradually for an hour
or so. Even with higher concentrations of di¬
benamine, adrenaline effects were slightly more
inhibited than 5-hydroxytryptamine effects. Both
antagonisms persisted when the dibenamlne was washed
away.
Guinea-pig's ileum was even less sensitive than
the rabbit's ear. Dibenamine (1000 l*g/l.) reduced
the responses to histamine and 5-hydroxytryptamine
about equally (52#) without affecting that to
acetylcholine. When the dibenamine was washed away
the response to 5-hydroxytryptamine returned, but
not that to histamine.
Dibenamine was thus found to be a powerful
antagonist for 5-hydroxytryptamine on the rat's
uterus (Erspamer, 1952b; 1953a). On the other two
tissues its action against 5-hydroxytryptamine was
feebler
feebler,and less than its aotion against adrenaline
ana histamine (Fingl and Gaddum, 1953). In contrast
so cne results with the rat's uterus and rabbit's ear,
che partial inhibition of the effect of 5-hydroxy¬
tryptamine on intestinal tissue by ergot alkaloids
and dibenamine was immediate and did not increase
with time.
SY-28 (N-ethyl-N-l-naphthylmetbyl-2-bromo-
ethylamine). This is known as an antagonist of
adrenaline and histamine (Graham and Lewis, 1953).
A concentration of 10 (ig/l. of SY-28 potentiated
the response to 5-hydroxytryptamine on the rat's
uterus and a concentration of 50-100 pg/l. inhibited
the effect of 5-hydroxytryptamine markedly. The
response to acetylcholine was also reduced, but
less than the 5-hydroxytryptamine effect. As with
dibenamine, the block developed gradually for an
hour or so. It was less active and less specific
than dibenamine for its anti-5-hydroxytryptamine
action on the rat's uterus.
SY-28 (50 p.g/1.) suppressed the vasoconstrictor
effects of 5-hydroxytryptamine and adrenaline on the
rabbit's ear to the same marked extent. The effect




The effect of SY-28 on guinea-pig's ileum was
un-specific. A concentration of 50 pg/l. produced
20$ inhibition of the response to 5-hydroxytryptamine
and 85;3 inhibition of the response to histamine. It
was thus more active against histamine than against
5-hydroxytryptamine.
When the drug was removed from the bath the
responses to 5-hydroxytryptamine and histamine showed
partial recovery.
The antagonism of SY-28 and 5-hydroxytryptamine
on the three tissues was clearly unspecific.
Freyburger et al. (1952) produced a partial
decrease of the 5-hydroxytryptamine induced hyper¬
tension in the dog with SY-28, while McCawley et
al. (1952) demonstrated that the sinus tachycardia
evoked In anaesthetised dogs by 5-hydroxytryptamine
could not be prevented with SY-28.
Inhibitors of amine oxidase. In low concen¬
trations ephedrine potentiates some of the actions
of adrenaline and In higher concentrations It
antagonises them (Gaddum and Kwiatkowski, 1938). The
former action has been attributed to the inhibition
of amine oxidase, which ephedrine is known to cause
and since 5-hydroxytryptamine is destroyed by amine
oxidase/
Figure 16
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Rabbit's ear perfused as in Fig. 4. Doses In ng
AD - adrenaline
HI - 5-hydroxytryptamlne
EPH - ephedrlne (1 mg/l.j 3.37-5.7)
increased the responses to adrenaline and HT.
In a higher concentration (10 mg/l.; 5.7-7.50)
ephedrine diminished the response to adrenaline,
but increased the response to HT still further.
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oxidase (Blaschko, 1952J Freyburger et al. 1952), It
was thought possible that some of its effects might
be Increased by ephedrine and allied drugs, Experi¬
ments with ephedrine and amphetamine on the rat's
uterus and the guinea-pig's ileum did not show any
significant action of this kind, A range of doses
from 1 n-g/l, to 500 M-g/l* of both drugs were tried.
The response of the perfused rabbit's ear to
5-hydroxytryptamine was greatly Increased when
ephedrine was present in the perfusion fluid.
Ephedrine in a concentration of 1 mg/l. in the
perfusion fluid potentiated the effects of both
adrenaline and 5-hydroxytryptamine, but when the
concentration of ephedrine was increased to 10 mg/l.
the response to adrenaline was actually depressed
while the response to 5-hydroxytryptamine was
markedly increased (Pig. 16). The potentiation of
the effect of 5-hydroxytryptamine is presumably due
to inhibition of the amine oxidase. The inhibition
of the response to adrenaline by higher concen¬
trations of ephedrine has been attributed to
blockade/
70.
blockade of the adrenaline receptors (Gaddum and
Kwiatkowski, 1938). The tryptamine receptors do
not appear to be blocked by the concentrations of
ephedrlne used In these experiments.
The theory that this potentiation of the
response to 5-hydroxytryptamine is due to Inhibition
of amine oxidase was confirmed by the results of
one experiment with cfoollne-p-tolyl ether (Hey,
1952j Brown and Hey, 1952). This drug, which is
known to inhibit amine oxidase markedly, was added
to the fluid perfused In a rabbit's ear In a
concentration of 1 mg/l. This increased the effect
of both adrenaline and 5-hydroxytryptamine, a higher
concentration (10 mg/l.) decreased both effects.
Choline-p-tolyl ether (1 pg-500 y.g/1.) like
ephedrlne and amphetamine, did not show any
significant effect of this nature on the rat's
uterus and the guinea pig's ileum.
Cocaine./
Figure 17
Rat's uterus - 2 ml. bath
AC - acetylcholine 500 ng
HT - 5-hydroxytryptamlne 10 ng
Cocaine (10 mg/l.; 5-17 mln)
increased the responses to acetyl¬
choline and HT. A higher concen¬
tration of cocaine (50 mg/l.; 37-
57 mln) decreased both these effects
70a
Cocaine.
Cocaine is not only a local anaesthetic
but also an inhibitor of amine oxidase (Philpot,
1940). Reid and Rand (1952) found that it increased
the effect of 5-hydroxytryptamlne on a strip of
sheep's carotid artery, but reported no experiments
to test whether this was a specific effect or an
unspecific increase in the contractile power of the
muscle. Cocaine, however, did not show any effects
which could be attributed, with confidence, to the
inhibition of amine oxidase.
In a concentration of 5-10 mg/l. it increased
the effects of both 5-hydroxytryptamine and acetyl¬
choline on the rat's uterus. When it was washed
away, the effects gradually returned to their
original level. Lower concentrations had no
significant action. A higher concentration,
.
(50 mg/l.) temporarily inhibited the effects of
both 5-hydroxytryptamine and acetylcholine. When the
cocaine was washed away the effects were increased
above their normal level (Pig. 17).
The action of 5-hydroxytryptamine on the
rabbit's/
Figure 18
Rabbit's ear perfused as In Fig. 4
AD - adrenaline
HT - 5-hydroxytryptamlne
Cocaine (10 mg/l.) Increased
the effect of adrenaline without signlfl
cant effect on the response to HT.
Figure 19
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COCAINE
Guinea-pig's Ileum - 2 ml, bath
AC - acetylcholine 4 ng
HT - 5-hydroxytryptamlne 140 ng
H - histamine 7 ng
Cocaine (10mg/l.) inhibited
markedly the response to HT with¬
out much effect on the responses
to acetylcholine and histamine.
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rabbit's ear was not significantly changed by
cocaine (10 mg/l.) although the action of adrenaline
was much increased in the same experiment (Pig. 18).
She small increase in 5-hydroxytryptamine response
seen in the figure is due to the increase in height
of the base line caused by the slight vasoconstrictor
effect of cocaine.
It has been suggested that the effect of cocaine
on the response to adrenaline Is due to inhibition
of amine oxidase (Philpot, 1940} Blashko, 1952). If
this is so, it is perhaps surprising that the cocaine
did not increase the effect of 5-hydroxytryptamine
in this experiment. It might be suggested that the
effect of 5-hydroxytryptamine on the rabbit's ear
does not depend on amine oxidase, but if so the
potentiating action of ephedrine cannot be explained
in the way that has been suggested above.
Cocaine (10 mg/l,) Inhibited the response of the
guinea-pig's ileum to 5-hydroxytryptamlne reversibly
without much effect on the response to histamine and
acetylcholine (Pig. 19).
In another experiment (Pig. 20) the responses to
5-hydroxytryptamine and nicotine were about equally
inhibiter
Figure 20
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COCAINE
Guinea-pigta Ileum - 2 ml. bath
C - carbachol 40 ng
N - nicotine 5000 ng
HT - 5-hydroxytryptamlne 1000 ng
Cocaine (5mg/l.) Inhibited the
responses to nicotine and 5-hydroxy-
tryptamlne without affecting the
response to carbachol.
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inhibited by cocaine (5 mg/l.). Both responses
recovered immediately when the drug was removed from
the bath.
This inhibition has been observed by others
(Slnha and West, 1953J Hocha e Silva et al. 1953)
and explained on the theory that 5-hydroxytryptamine
acts on the nervous tissue in the intestine and that
cocaine inhibits its action by paralysing these
nerves.
The actions of cocaine on these three tissues
were thus different. The response of the rat's
uterus was unspeclfically increased by low concen¬
trations and unspecifically decreased by higher
concentrations. The response of the rabbit's ear
was unaffected and the response of the guinea-pig's
ileum was Inhibited, like the response to nicotine
before the responses to histamine or choline esters.
The generalisation of Sinha and West (1953) that
local anaesthetics antagonise the actions of 5-
hydroxytryptamine does not give all the facts.
Atropine. In concentrations of 5-100 M-g/l.
atropine completely abolished the effect of choline
esters on the rat's uterus while leaving the effect
of/
Figure 21
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Hat's uterus - 2 ml* bath - interval 3 min.
ST - 5-hydroxytryptamlne 20 ng
C - carbaehol 100 ng
T - tryptamlne 4000 ng
Atropine (5 t*g/l. during time signal)
abolished the response to carbachol but had
no effect on the response to HT or tryptamlne.
Figure 22
Guinea-pig*s Ileum - 2 ml. bath - interval 3 min.
HT - 5-hydroxytryptamlne 100 ng
C - carbachol 10 ng
CB - cinobufotenin 1200 ng
(N-trlmethyl-5-hydroxytryptamlne)
Atropine (10 ng during time signal)
suppressed the response to carbachol but
not that to HT. With cinobufotenin the
effect was Intermediate.
Figure 23
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ATROPINE
Guinea-pig's ileum - 2 ml. bath
H - histamine 7 ng
AC - acetylcholine 7 ng
HT - 5-hydroxytryptamine 130 ng
Atropine (100 M-g/l.) nearly
abolished the effect of acetyl¬
choline and markedly diminished
the effect of HT but did not alter
the effect of histamine.
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of 5-hydroxytryptamine unchanged (Pig. 21). A
higher concentration 1000 Hg/l.) diminished the
effect of 5-hydroxytryptamine by 50%.
Atropine (5 |xg/l.) abolished the response of
the guinea-pig's ileum to carbachol (5 ^g/l.) but
not that to 5-hydroxytryptamine (50 pg/l.) (Ftg 22).
The effect of cinobufotenin, (CB) was partially
inhibited. Higher concentrations of atropine
(100 diminished the effect of 5-hydroxy¬
tryptamine and abolished the effect of acetylcholine
(3-5 ng/l«) while leaving that of histamine (3-5pg/l.)
unchanged (Pig. 23). These results confirm those of
various workers (Gaddum, 1953a; Rapport and Koelle,
1953J Robertson. 1953; Rocha e Sllva et al. 1953).
Atropine inhibits the effect of 5-hydroxytryptamine
on this tissue more than that of histamine, but less
than those of choline esters. The effects of
5-hydroxytryptamine and nicotine were inhibited to
about the same extent by atropine in this tissue.
The actions of atropine on the guinea-pig's ileum
are thus similar to those on the rat's uterus, but
there was less difference between the doses effect¬
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MEPYRAMI N E
Guinea-pig's ileum - 2 ml, bath - interval 3 min.
HT - 5-hydroxytryptamine 200 ng
H - histamine 10 ng
CB - cinobufotenin 1000 ng
Mepyramlne (5p.g/l.) inhibited the
response to histamine but not that
to HT or cinobufotenin.
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Atropine (100-1000 Hg/l.) had no aotlon on the
effect of 5-hydroxytryptamine on the rabbit's ear.
Antihistamines. Experiments were done with
mepyramine and diphenhydramine. The first is one of
the most specific antihistamines, and the second is
less specific since it has some action against
acetylcholine (Schild, 1947). The effect of
5-hydroxytryptamine on the rat's uterus was partially
blocked by either drug in a concentration of 100pg/l.
and completely blocked by 1000 yg/l. In both cases,
the response to acetylcholine was inhibited. With
diphenhydramine the acetylcholine response was
inhibited to the same extent as the response to
5-hydroxytryptamine, while mepyramine (1000 pg/l.)
caused only 54$ inhibition of the response to
acetylcholine.
Mepyramine (1000 Hg/l.) had little or no effect
on the response of the guinea-pig's ileum to 5-
hydroxytryptamine or acetylcholine although a con-
centration of 5 pg/l. was sufficient to abolish the
response to histamine (Pig.24). Diphenhydramine
(1000 |ig/l.) produced partial inhibition of the
responses to both 5-hydroxytryptamine and acetyl¬
choline, and abolished the response to histamine
almost/
Figure 25
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diphenhydramine
Guinea-pig's ileum - 2 ml. bath
A.C - acetylcholine 10 ng
H - histamine 13 ng
HT - 5-hydroxytryptamine 100 ng
Diphenhydramine (lrng/l.)
caused partial Inhibition
of the responses to HT and
acetylcholine but abolished
the response to histamine
almost completely.
Figure 26
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DIPH.
Guinea-pig's ileum - 2 ml. bath - Interval 3 mln.
H - histamine io ng
HT - 5-hydroxytryptamlne 500 ng
Dlph - diphenhydramine (25 p-g/l.) caused
marked inhibition of the response to
HT and almost completely abolished the
response to histamine. After diphen¬
hydramine was removed from the bath,
the response to HT recovered earlier
than that to histamine.
Figure 27
HT CB N HT CB N HT CB N HT
HEXAMETHONIUM 20 juc).
Guinea-pig'a ileum - 2 ml. bath - Interval 5 min.
N - nicotine 3000 ng
HT - 5-hydroxytryptamine 150 ng
CB - cinobufotenln 1500 ng
Hexamethonium abolished the response to
nicotine and decreased the response to CB but had
no effect on the response to HT
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almost completely (Pig. 25). In another experiment
(Pig. 26)diphenhydramine in a low concentration
(25 M-g/l.) diminished the response to 5-hydroxy-
tryptamine to a marked extent* After the drug was
washed out, the response to 5-hydroxytryptamine
recovered earlier than that due to histamine.
These two antihistamines thus produced about the
same effect on the responses of both tissues to
5-hydroxytryptamine as on their responses to acetyl¬
choline. The experiment with the guinea-pig's
ileum provides another example confirming the
generalisation that mepyramine is a more active and
more specific antihistamine than diphenhydramine.
These results are in general agreement with those
of Reid and Rand (1951 and 1952),Rrspamer (1952b) and
Rapport and Koelle (1953).
Inactive or unspecific antagonists. The
following drugs showed no specific antagonism to
5-hydroxytryptamine.
Hexamethonium (10 mg/l.) Inhibited the effect of
nicotine on the guinea-pig's ileum without altering
the effect of 5-hydroxytryptamine (Fig .2?) The response
to cinobufotenin (CB) was also partially suppressed.
The/
Figure 28
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YOHIMBINE
Rat's uterus - 2 ml. bath
HT - 5-hydroxytryptamlne 5 ng
AC - acetylcholine 300 ng
T - tryptamlne 2000 ng
Yohimbine (5mg/l.) inhibited
the responses to HT and tryptamlne
more than that to acetylcholine.
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The actions of this compound are described on P.84
This confirms the results of Robertson (1953) and
Rocha e Sllva et al. (1953).
Mescaline (50 pg-50 mg/l.) did not affect the
response of the rat's uterus to 5-hydroxytryptamine.
Higher concentrations of the drug (^>1 mg/l.)
caused contraction of the uterus. These were kept
in the bath for 10 minutes and then washed out, when
the subsequent direct effect of 5-hydroxytryptamine
was not affected. Mescaline Is thought, by some,
to resemble lysergic acid diethylamide in Its
effects on the central nervous system. These two
drugs might therefore have been expected to have
similar effects as antagonists of 5-hydroxytryptamine
but this was not the case.
Yohimbine (5 mg/l^ markedly depressed the
response of the rat's uterus to 5-hydroxytryptamine
and tryptamlne (Rig.28). The response to acetyl¬
choline was also depressed though less, and the
antagonism was thus not very specific. Low concen¬
trations (500 H-g/1.) had no effect on the responses
to 5-hydroxytryptamine and tryptamlne, The
antagonism between yohimbine and tryptamine on the
blood pressure of dog was described by Raymond-Hamet
(1941).
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(1941). The antagonism of yohimbine and 5-hydroxy-
,<k- •
tryptamine on isolated strips of carotid artery has
been described by Held and Rand (1952) and Shaw and
Woolley (1953), These authors obtained effects
with concentrations as low as 0.1 mg/l. but give no
evidence that the inhibition was specific. Arspamer
(1953a) however, reported that 1 mg/l. of yohimbine
did not affect the response to 5-hydroxytryptamlne
on the rat's uterus, but 10 mg/l. showed a consist¬
ent depressive effect on the response to 5-hydroxy-
tryptamine without any effect on the response to
acetylcholine.
Physostlgmlne in low concentrations (100-1000
Wj/l*) caused a small increase in the response of
the rat's uterus to 5-hydroxytryptamine and higher
concentrations (10-50 mg/l.) sometimes caused a
decrease, but the effects were feeble.
Although both yohimbine and eserlne contain an
indole ring there is, as yet, no evidence that
either of them is a specific antagonist of 5-hydroxy
tryptamine.
Adrenaline. In concentrations of 1-100 Hg/l.
adrenaline/
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adrenaline caused marked inhibition of tlie effect of
tryptamlne on rat's uterus. The effect was un-
specific, as carbachol was likewise inhibited. The
effect of adrenaline on the guinea-pig's ileum was
not tested. Rocha e Sllva et al. (1953) reported
that adrenaline (333-334 pg/l.) caused marked
inhibition of the response of the guinea-pig's ileum
to 5-hydroxytryptamine. The responses to histamine
and acetylcholine were also depressed by adrenaline.
Tyramine. In concentrations of 500-1000 Hg/l.
tyramine did not inhibit the response of the rat's
uterus to tryptamine, but the effeot of carbachol
was strongly suppressed. Tyramine did not cause
stimulation of the uterus in the doses used. Its
effect on the guinea-pig's ileum was not tested.
Lrspamer (1952b; 1953a) reported that adrenaline
strongly inhibited the uterus stimulating action of
enteramine, but the other sympathomimetic drugs
(tyramine, norsynephrine, noradrenaline) counter¬





Experiments with specific antagonists confirm
the conclusion that 5-hydroxytryptamine produces
some of Its effects by acting on specific receptors.
Vs'lth mepyramlne, piperoxane and atropine it is
possible to abolish the effects of histamine,
adrenaline and acetylcholine respectively, without
altering the effects of 5-hydroxytryptamine.
Higher concentrations of these drugs may antagonise
5-hydroxytryptamine, but this does not invalidate
the evidence given by the experiments with low
concentrations which show that some at least of
the effects of 5-hydroxytryptamine are due to
combination with receptors which are not identical
with the receptors for histamine, adrenaline or
acetylcholine.
The drugs which do antagonise 5-hydroxytrypta¬
mine have given different results when tested on
different tissues. Lysergic acid diethylamide
is a very active and specific antagonist for
5-hydroxytryptamine In experiments on the rat's
uterus or the rabbit's ear, but had little effect in
experiments/
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experiments on the guinea-pig's ileum even when high
concentrations were used. Other ergot alkaloids
and gramine gave similar though less striking
results. These drugs were more effective on the
rat's uterus and the rabbit's ear than on the guinea-
pig's ileum, but the reverse is true of atropine,
cocaine, or excess of 5-hydroxytryptamine itself.
Other workers (Robertson, 1953} Rocha e Silva
et al. 1953) have obtained similar results with the
last three drugs on guinea-pig's ileum, and have
suggested a theory to account for them. The effect
of 5-hydroxytryptamine on this tissue resembles that
of nicotine in that both effects are blocked by
similar concentrations of atropine and cocaine. It
is therefore suggested that 5-hydroxytryptamine acts,
like nicotine, at some point in the nervous tissue
in the intestine. Hexamethonium, or sufficient
excess of nicotine, blocks the response to small
doses of nicotine without blocking the response to
5-hydroxytryptamine. These facts are explained on
the theory that 5-hydroxytryptamine acts on the post¬




This theory does not provide a satisfactory
explanation of the observation of Rocha e Silva et
al. (1953), that when the guinea-pig's Ileum is
desensitized to 5-hydroxytryptamine by excess of
5-hydroxytryptamine itself, it still gives a normal
response to nicotine. If the site of action of
5-hydroxytryptamine is peripheral to that of nicotine
and is paralysed, it is surprising that the response
to nicotine is normal. Nicotine and 5-hydroxy¬
tryptamine appear to behave similarly to one another
but independently; if the bath contains excess of
either of these drugs the muscle gives no response to
that drug, but a normal response to the other drug.
There is nothing to suggest an anatomical difference
between the sites of action of the two drugs. It Is
possible that the ganglion cells in the intestine
contain two types of receptor, one of which is stimu¬
lated by acetylcholine or nicotine and inhibited by
excess of nicotine or hexamethonium, while the other
type is stimulated by 5-hydroxytryptamine and inhibit¬
ed by excess of 5-hydroxytryptamine. These cells
would then be comparable with various plain muscle
cells which are believed to have specific receptors
for/
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for both histamine and acetylcholine. It is also
possible that there are two types of cell, one of
which is stimulated by nicotine and the other by
5-hydroxytrypfcamine,
Whatever may be the explanation of the behaviour
of the guinea-pig's ileum, it Is clear that the other
two tissues behave differently. The results can be
explained on the theory that there are two types of
tryptamine receptors.
A. Receptors in the plain muscle of the
rat's uterus and rabbit's ear which are
easily paralysed by lysergic acid di¬
ethylamide but not so easily paralysed
by excess of 5-hydroxytryptamine.
B. Receptors in the ganglia of the
intestine which are easily paralysed by
excess of 5-hydroxytryptamine but not
easily paralysed by lysergic acid di¬
ethylamide .
If this theory is correct, the relation between
lysergic acid diethylamide and 5-hydroxytryptamine is
similar to the relation between acetylcholine and
atropine. In both cases, the receptors in smooth
muscle are more easily inhibited by the antagonist,
and the receptors in the nervous tissue are more
easily desensitized by excess of the active drug.
SECTION IV.
ACTION OP RELATED INDOLE COMPOUNDS.
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Preliminary study of Indole compounds.
In the preliminary study, the following
Indole compounds were tested on the rat's uterus and
the guinea-pig'a Ileum especially for their antagon¬
ism to the effects of 5-hydroxytryptamlne and
tryptamine; gramine, clnobufotenin, vlrldo-
hufotenin, marlnobufotenln, indole, 2-methyl indole,
3-methyl Indole (skatole), 7-methyl indole, 3-indo-
lyl-acetic acid, methyl-3-Indolyl acetate, indole
propionic acid, Indole butyric acid, isatln, lsatin-
p-oxlmt, tryptophan, hypaphorine, adrenochrome and
adrenolutine.
The actions of tryptamine bear a close
resemblance to those of 5-hydroxytryptamine (Reld,
1951; Gaddum, 1953a). It is however, very much les3
active than 5-hydroxytryptamine, 200-500 times less
active on the rat's uterus and 300 times or more,
less active on the guinea-pig's ileum. The drugs
which antagonised 5-hydroxytryptamine, also antagonised
tryptamine.
Guinea-pig's Ileum can be specifically desensi¬
tized to tryptamine by exposure to high concentrations
of/
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of this drug or 5-hydroxytryptamine (Gaddum, 1953a).
Similar experiments with high concentrations of
ryptamine were carried out on the rat's uterus, but
the persistence of muscular contractions in the
presence of tryptamine interfered with the results.
The phenomenon of tachyphylaxis was frequently
observed on guinea-pig's ileum with tryptamine. The
results of most of the experiments with this drug are
described in conjunction with 5-hydroxytryptamine.
Tryptamine was not very active on the guinea-pig's
ileum and few experiments were done on this prepar¬
ation.
Gramine. The effects of gramine are described on
P.54-55. Gramine (0.5-50 mg/l.) inhibited the response
of the guinea-pig's ileum to histamine sometimes less
and sometimes more than the effects of 5-hydroxy-
tryptamine and tryptamine. Frequently, it gave rise
to small sustained contractions of the guinea-pig's
ileum.
Clnobufotenln. It was about 2000 times less
active than 5-hydroxytryptamine on the rat's uterus.
High concentrations of the drug (6.5-50 mg/l.) caused
marked/
Figure 29
ftat^s uterus - 2 ml. bath
HT - 5-hydroxytryptamlne 5 ng
ikC - acetylcholine 200 ng
T - tryptamine 2000 ng
CB - clnobufotenln (6.5 mg/l.) for
10 mln and washed out. The
response to acetylcholine was
abolished but responses to HT
and tryptamlne were unchanged.
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marked contraction of the uterus. These concentrations
were kept in the "bath for 10 minutes and then washed
out. The subsequent direct effects of 5-hydroxy-
tryptamine and tryptamine were immediately increased
above the normal level but the effect of choline
ester was completely inhibited (Pig.29). Low
concentrations (1.25-2.5 mg/l.) of the drug
occasionally produced slight potentiation of the
response to carbachol. Cinobufotenin is an
inhibitor of cholinesterase (Sobotka and Antopol,
1937). The effects of cinobufotenin on the response
to the choline ester may perhaps be explained on the
same basis as those of eserine and ephedrine on the
responses to acetylcholine and adrenaline. Low
concentrations of eserlne and ephedrine potentiate
and higher concentrations of these drugs inhibit
some of the actions of acetylcholine and adrenaline
respectively.
As compared to the rat's uterus, cinobufotenin
was 200 times more active on the guinea-pig's ileum.
It was l/lO as active as 5-hydroxytryptamine on this
preparation. In a concentration of 12.5 mg/l. it
gave a sharp contraction of guinea-pig's ileum
followed/
Figure 30
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COCAINE
Guinea-pig's Ileum - 2 ml. bath
CB - cinobufotenln 1500 ng
H - histamine 10 ng
Cooaine (10 mg/l.)
abolished the response to CB
but potentiated that to
histamine.
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followed by immediate relaxation. This concen¬
tration was then kept in the bath. The response to
6-hydroxytryptamine was completely blocked and the
effect of histamine was partially inhibited.
Atropine in a concentration of 5 Hg/l* caused
partial inhibition of the effect of cinobufotenin
on guinea-pig's ileum (Pig.22). The effect of
5-hydroxytryptamlne was unaffected, while the
response to carbachol was completely abolished in
the same experiment.
Hexaraethonlum in a concentration of 10 mg/l.
produced partial inhibition of the response to
cinobufotenin, but nicotine was completely blocked
(Fig.27 ).
Cocaine (10 mg/l.) completely abolished the
response to cinobufotenin, but the response to hist¬
amine was potentiated (Pig. 30). Cocaine in this
experiment, stimulated the guinea-pig's gut,
(Feldberg and Lin ^ 1949 ).
High concentrations of 5-hydroxytryptamlne
(30 mg/l.) and tryptamine (50-100 mg/l.) desensitized
the guinea-pig's ileum to 5-hydroxytryptamine and
tryptamine but produced partial block of the response
to cinobufotenin.
The above results seem to indicate that the
action/
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action of cinobufotenin on the guinea-pig's ileum
consists of two components, the 5-hydroxytryptamlne-
like and the nicotine-like. The effect of the
5-hydroxytryptamine-like component was blocked by
high concentrations of 5-hydroxytrypfcamine, but not
affected by hexamethonium, while the reverse was true
for the nicotine-like component. Cocaine completely
inhibited the effect of cinobufotenin and cocaine is
known to abolish the effects of both 5-hydroxytrypta¬
mine and nicotine.
If the theory (P.82) that 5-hydroxytryptamine
and nicotine act on separate reeeptors or cells in
the parasympathetic ganglia in the guinea-pig's ileum
is accepted, then it seems most likely that cino¬
bufotenin (the quartenary base corresponding to
5-hydroxytryptamine) acts on both these sites. The
evidence for such an assumption is not yet conclusive
The inhibition of the effect of einobufotenin by
y
a small dose of atropine (5 ti-g/l.) is not fully undetf
stood. It may be explained on the assumption that
the nicotinic effect is more easily suppressed by
atropine than the 5-hydroxytryptamine effect.
Virido/
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VIrldobufotenin B. It was Isolated from the
parotid secretion of the green toad of Europe, Bufo
Vlrldls Viridis (Chen, Jensen and Chen, 1933) in the
form of a flavianate and gives positive reactions in
Indole tests. It has the following composition:
CiaH8008Ka.CxoHe08NaS.
VIrldobufotenin was found to have very little
blood pressure raising power, having only 4 per cent
of the pressor activity of cinobufotenin flavianate.
It increases the tone of the frog's heart, stimulates
Isolated rabbit's intestine in the concentration of
1:10® and causes spastic contractions of the isolated
guinea-pig's uterus in a solution of 1:200,000 (Chen,
Jensen and Chen, 1933).
A very small sample of this drug was available
and therefore its effects could not be properly
studied.
It stimulated the rat's uterus and was 20 times
more active than cinobufotenin on this preparation
and 100 times less active than 5-hydroxytryptamlne.
In a concentration of 100-2500 M-g/l. it did not affect
the responses of the rat's uterus to 5-hydroxy-
tryptamine, tryptamine and carbachol.
It/
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It also stimulated the guinea-pig's ileum and
had about the same activity on this preparation as
on the rat's uterus when compared with 5-hydroxy-
tryptamine.
Cinobufotenin, however, was about 20 times more
active than vlridobufotenin on the guinea-pig's
ileum. In concentrations of 2500 |ig/l. it had no
significant effect on the responses to 5-hydroxy-
tryptamine and histamine.
Marlnobufotenin. Chen, Jensen and Chen (1932)
Isolated marinobufotenin as the flavianate from the
parotid secretion of the Jamaican toad or Bufo
marlnus. Its pharmacological actions were studied
by Chen and Chen (1933b). It gives a positive indole
reaction and has the following composition:
CiaH14OsNa.C10He08NaS.
The physiological effects of marinobufotenin
are much less prominent than those of olnobufotenin.
In pithed cats, doses from 0.25 to 0.5 mg of the
flavianate caused practically no increase in blood
pressure. There was a slight decrease of the frog's
heart rate and slight increase in its tone. A
concentration of 1:200,000 brought about contractions
of/
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of the isolated guinea-pig's virgin uterus, but had
no effect on the isolated rabbit's intestine.
In concentrations of 1.25-25 mg/l. it caused
slight stimulation of the rat's uterus and had no
effect on the responses to 5-hydroxytryptamlne,
tryptaraine and carbachol.
Marino-bufotenin (25 mg/l.) did not cause any
stimulation of the guinea-pig's ileum and had no
effect on the contractions of 5-hydroxytryptamine and
histamine.
Indole. In concentrations of 5-25 mg/l. indole
produced a feeble stimulant effect on the rat's
uterus and inhibited the responses to tryptamine but
the effect of carbachol was likewise inhibited.
On the guinea-pig's ileuxn^ indole (0.5 - 5 mg/l.)
occasionally produced excitation and caused slight
inhibition of the responses to 5-hydroxytryptamine,
tryptamine and histamine. In concentrations of
50 rag/l. it produced marked contraction followed by
immediate relaxation, and the subsequent effects of
5-hydroxytryptamine, tryntamine and histamine were
markedly inhibited.
2, 3 and 7-methyl indoles are Insoluble and
their saturated solutions were used.
2-methyl/
Figure 51
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Hat's uterus - 2 ml. bath - Interval 3 mln.
HT - 5-hydroxytryptamine 20 ng
C - carbachol 100 ng
T - tryptamine 4000 ng
2-methyl Indole ( 25 mg/l. during time
signal) abolished the responses to HT
and tryptamine without affecting the
response to carbachol.
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2-methyl Indole in concentrations not greater
than 25 mg/l, inhibited the responses of the rat's
uterus to 5-hydroxy tryptamine and tryptamine, but
had no effect on the response to carbachol {Pig.31).
On the guinea-pig's ileum, 2-methyl indole in
concentrations not greater than 50 mg/l. produced
a non-specific inhibition of the effects of 5-
hydroxytryptamine and tryptamine, as the response
to histamine was also inhibited to a marked extent.
3-methyl indole (skatole) in concentrations not
greater than 50 mg/l, inhibited the response of
rat's uterus to tryptamine to a marked extent, but
the response to carbachol was also inhibited though
less than that to tryptamine.
On the guinea-pig's ileum, in the same concen¬
trations as were used on the rat's uterus, it
inhibited the responses to 5-hydroxytryptamine,
tryptamine and histamine.
Skatole was less active and less specific as
compared to 2-methyl indole. Both 2-methyl indole
and skatole are also known as antihistamine agents
(Bunyatyon and Matlnyon, 1948).
7-methyl/
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7-methyl indole In concentrations not greater
than 50 mg/l. inhibited completely the effect of
tryptamine on the rat's uterus and caused marked
inhibition of the response of this preparation to
carbachol.
On the guinea-pig's ileum in concentrations not
greater than 25 mg/l. it sometimes produced stimu-
■
lation and had no effect on the responses to 5-
hydroxytryptamine, tryptamine and histamine.
5-indolyl-acetic acid (Ifeteroauxin). 3-indolyl-
acetic acid (10 - 25 mg/l.) markedly inhibited the
effects of 5-hydroxytryptamine, tryptamine and
carbachol on the rat's uterus.
On the guinea-pig's ileum, 3-indolyl-acetie acid.
(0.5 - 50 mg./l.) produced a partial inhibition of
the responses to 5-hyiroxytryptamine, tryptamine and
histamine. The response to histamine was slightly
more inhibited than the response to 5-hydroxytrypta¬
mine or tryptamine. Occasionally, it produced a
feeble stimulation of the guinea-pig's ileum.
Methyl-5-lndolyl acetate (5 - 50 mg/l.) caused
marked inhibition of the responses of rat's uterus
to 5-hydroxytryptamine and tryptamine. The effect
of a choline ester was also inhibited. Occasionally
it/
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it produced contractions of the rat's uterus.
On the guinea-pig's ileum it was more active
than the 3-indolyl-acetic acid. In concentrations
of 25 - 50 mg/l. it inhibited the effect of 5-
h^droxytryptamine to a marked extent. The response
to histamine was also greatly suppressed. Like
3-indole-acetic acid, it occasionally caused stimu¬
lation of the guinea-pig'3 ileum.
Indole-propionic acid (25 mg/l.) had no effect
on the responses of the rat's uterus to carbachol
and tryptamine.
On the guinea-pig's ileum, it (5 - 50 mg/l.)
produced a slight inhibition of the effect of 5-
hydroxytryptamine, tryptamine and histamine.
Indole-butyrlc acid was insoluble and a satur¬
ated solution was prepared. It did not show much
activity in the concentrations used.
In concentrations not greater than 25 mg/l. it
had no effect on the responses of the rat's uterus.
It caused a weak contraction of the rat's uterus.
Indole-butyrie acid in concentrations not
greater than 50 mg/l. had no effect on the actions
of 5-hydroxytryptamine and tryptamine on the guinea-
pig's ileum. The response to histamine was partially
inhibited./
Inhibited.
Isatin (2i3-indollnedione) was also inactive.
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of the rat's uterus and the guinea-pig's ileum to
5-hydroxytryptamine and tryptaiaine.
Isatin-g-oxlms was insoluble and a saturated
solution was used. In a concentration not greater
than 50 rag/l. it caused marked inhibition of the
effects of 5-h^droxytryptamine and partial inhibition
of the effect of tryptamine on the rat's uterus, with-
out much effect on acetylcholine response.
On guinea-pig's Ileum, lsatln-j^-oxime was not
very active. In concentrations not greater than
50 mg/l., it caused a partial inhibition of the
responses to 5-hydroxytryptamine and tryptamine.
The response to histamine was also partially blocked.
Tryptophan did not produce any significant
effect on the responses of the rat's uterus and the
guinea-pig's ileum to 5-hydroxytryptamine or trypta¬
mine. The effects of choline esters and histamine
were also not significantly affected. On guinea-
pig's ileum concentrations of 50 mg/l. produced only




Hypaphorine (tryptophan-betaine ), in concen¬
trations of 1.25 - 25 mg/l., caused spontaneous
activity of the rat's uterus, hut had no inhibitory
effect on the responses to 5-hydroxytryptamine and
tryptamine.
On the guinea-pig's ileum, hypaphorine (50mg/l.)
caused no stimulant effect and had no action on the
responses to 5-hydroxytryptamine and histamine.
Adrenochrome, was prepared by the action of
silver oxide on adrenaline in methyl alcohol,
(Braconier, Le Bihan and Beaudet, 1943). Its
solution was made in ascorbic acid and tested when
fresh.
In concentrations of 50p,g/l. it markedly
.
.
inhibited the effect of tryptamine on the rat's
uterus. A concentration of 500p,g/i. completely
abolished the response to tryptamine. The effect
of carbachol was likewise inhibited by the same
concentrations.
Higher doses of adrenochrome (5-50 mg/l.) were
required to abolish the effect of 5-hydroxytryptamine
on the guinea-pig's ileum. The response to histamine
was/
96,
was also inhibited though less than that to 5-hydroxy-
tryptamine.
It was considered that part of the effect of
adrenochrome might be due to the presence of small
quantities of active adrenaline in it. The effects
of adrenochrome, therefore, were compared with those
of a standard solution of adrenaline on the rat's
uterus, and the rat's colon by the method depending
on inhibition of the contractions of these tissues
induced by carbachol (Gaddum, Peart and Vogt, 1949).
The following results were obtained.
Hat's uterus:
1 ng of adrenaline = 300 ng of adrenochrome.
Hat's colon:
20 ng of adrenaline = ^==*10,000 ng of adrenochrome
15,000 ng of adrenochrome
(ratio 500 to 750).
lex- uk. ^5 o~*—
When compared with the response to tryptamine on the
rat's uterus, 0.5 ng adrenaline = 300 ng adrenochrome
(ratio 600). The above results did not give a
significant difference between the effects of
adrenochrome and adrenaline on the two tissues tested.
as the effect of tryptamine was also inhibited by
very/
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very low concentrations of adrenaline (1 \ig/l. or
less), the presence of 0.17 > of adrenaline in the
adrenochrome could not be ruled out. The concen¬
trations of adrenochrome actually used to inhibit
the response of the rat's uterus to tryptamine were
50 - 500 {Ag/l. On the guinea-pig's ileum, still
higher concentrations (5 -50 mg/l.) of adrenochrome
were used to inhibit the effect of 5-hydroxytryptamine.
It did not produce any stimulation of the rat's
uterus or the guinea-pig's ileum In the concentrations
used.
Adrenolutine it was insoluble and very
unstable. It was used in the form of a very fine
emulsion. Adrenolutine(concentration not greater
than 50 mg/l.) caused marked inhibition of the
response of the rat's uterus to tryptamine. The
effect of carbachol was also inhibited though not
to the same extent as that of tryptamine. It did
not stimulate the rat's uterus In the concentration
used.
On the guinea-pig's ileum, adrenolutine (concen¬
tration not greater than 50 mg/l.) produced a small
sustained contraction and partially inhibited the
responses/
98.
responses to both 5-hydroxytryptamine and histamine.
The results of the experiments with all the
above indole compounds are listed in Table I and II.
This preliminary study revealed that all these
Indole compounds produced an unapecific inhibition
of the effects of 5-hydroxytryptamine and trypfeamine
on the guinea-pig*s ileum. In all cases, the
effect of the control drug, histamine, was also
inhibited although in most cases less than the
effects of 5-hydroxytryptamlne and tryptamine.
On the rat*s uterus, gramine and 2-methyl-
indole produced specific inhibition of the effects
of 5-hydroxytryptamine and tryptamine in the sense
that the response to a choline ester was unaffected
by these drugs In the concentrations used. Isatin-
p-oxime also produced specific inhibition of the
effects of 5-hydroxytryptamine and tryptaraine but
its action was feeble, All the other drugs caused
an unspecific effect. Gramine was the most active
antagonist for 5-hydroxytryptamlne. It formed a
prototype for the new synthetic compounds prepared
by Messrs. Glaxo. Their actions and relative
antagonistic activities are described In the next
section.
98a.
Key to abbreviations used in TABLES I and II:
® — Acetylcholine or carbachol.
x - not tested
0 - no Inhibition
SI - slight inhibition (5-15$)
PI - partial inhibition (16-50$)
MI - marked inhibition (^50$)
CI - complete inhibition
S - saturated aqueous solution
1 - fine emulsion
+ - unsustained contraction
++ - contraction - relaxation, but spontaneous
activity. Tested with agonists when
spontaneous activity ceased.
* - occasional contraction
- no direct effect, spontaneous contractions
set In after some minutes, which ceased
after washing out. Agonists then added.
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S Saturated, aqueous soln. No direct eff ect, spontaneous con¬
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Quantitative analysis of ant1-5-hydroxytryptamlne
potencie s of indole compounds.
A large series of indole and carbazole
derivatives were tested in order to find a specific
and potent anti-5-hydroxytryptamlne agent. The anti-
5-hydroxytryptamlne potencies of various ergot
alkaloids, dibenaraine, atropine, mepyramine and di¬
phenhydramine were also estimated. The antagonism
of some of these drugs and 5-hydroxytryptamine have
been studied by Lrspamer (1954) and Shaw and Woolley
(1953).
Experiments in which antagonistic drugs are
: I
compared with one another are complicated by the fact
that there is no generally accepted way of measuring
their potencies. Rough measurements may be made by
finding the dose necessary to abolish the effect of
the active drug ("the agonist") completely. Such
measurements are unlikely to he very accurate since
the result will depend on the dose of agonist used,
and on the sensitivity of the record to small effects
produced In the presence of the antagonist. A few
preliminary experiments of this type were performed




It is probably more satisfactory to use a method
depending in some way on a measurement of the effect
produced by the antagonist.
When the effect of a given dose of agonist is
inhibited completely^ it is generally found that
larger doses are still effective, but can be
blocked by larger doses of the antagonist. Such
results are sometimes described by calling the
antagonism competitive (Shaw and Woolley, 1953).
This practice may lead to confusion since it suggests
that it has been proved that the two drugs are com¬
peting with one another for the same receptor in the
tissue. It has however, been pointed out (Gaddum,
1943) that studies of the quantitative relations
between the concentrations of antagonists needed for
a constant effect provide no evidence to distinguish
the theory that the drugs are competing with one
another for the same receptor, and the theory that
the drugs are combining with one another to form an
inactive complex. The expression "competitive
antagonism7' has been used for so long to describe
the first of these theories, that it would be
difficult to alter its meaning now. Some other
word/
113.
word therefore, needed to describe the actual
observation that over a certain range of doses an
increase of the dose of either drug overcomes the
effect of its antagonist. It is proposed to call
this type of antagonism surmountable.
The measurement of the effect of the antagonist
The effect of the antagonist may be
measured in terms of the percentage reduction of the
recorded response to the agonist. This is only
possible in a limited range of doses of the antagon¬
ist and is unlikely to give constant results. When
experiments are made on isolated organs, measurements
are therefore generally made of the following quanti¬
ties.
&c - the concentration of the agonist which has
a glvv-ij effect (y) in the absence of the antagonist.
4 - the concentration of the agonist which has
the same effect in the presence of the antagonist in
concentration B and at time t.
The dose ratio (A/A0 ) when the antagonism is
surmountable is often taken as a measurement of the
effect produced by the antagonist, sometimes it is
independent of y, so that the log dose effect curves
before and after the antagonist are parallel. This
is/
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is however, not always so (Scbild, 1949).
Cases are known in which k/h0 increases with y,
so that the antagonist makes the log dose effect,
curve flatter, and cases are also known where the
reverse is true. The quantity A/A0 can then only
he used as an expression of the effect of the
antagonist if y is kept constant and uchild (1949)
has proposed that it should be 50 per cent of the
maximum effect.
Hocha e Silva and his colleagues (Rocha e Silva
and Beraldo, 1948; Beraldo and Rocha e Bilva, 1949;
Rocha e ^ilva, 1950) have suggested that the effect
of «n antagonist should be measured in terms of the
time the muscle takes to recover when the antagonist
is removed from the bath. They have studied this
recovery in some detail and use more than one way of
expressing their- results, but the simplest one is RSc
which is the time in seconds for the muscle to
recover sufficiently to give a contraction half as
great as the original contractions. This time
increases with the dose and can be used as a measure
of the effect of the antagonist. There is no
evidence that the use of this quantity avoids the
complications/
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complications described above due to the fact that
A/A0 is not independent of y. Rocha e .Sllva et al.
avoid such complications by using a constant dose of
the agonist.
The importance of this kind of measurement is
emphasized by the work of Pleckenstein (1952) who
found that the actions of specific antagonists often
lasted longer than those of less specific drugs. On
the other hand, duration of the action is not the
only property of drugs which may be worth measuring.
Mepyramine antagonises the action of histamine
on the guinea-pig's ileum in lower doses than
promethazine but its action does not last so long
(Reuse, 1948). If the meta meter proposed by Rocha
e dilva et al. were used as the only criterion of
the action of the antagonists, such differences would
be obscured. In any case, some drugs have such a
prolonged action that the use of this method of
investigation would be impossible (Ga&aum, 1926).
For these reasons, the ratio A/A0 is probably
a more generally useful measure of the effect pro¬
duced by an antagonist .
The/
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The measurement of the potency of antagonists.
The potencies of antagonists may be com¬
pared by measuring, for each, the concentration (B)
needed to have a standard effect (A/A0 ), in a
standard time. This is the basis for the calculation
of the pAx, which is the negative logarithm of the
molar concentration where A/a6 is x (Bchild, 1947).
This quantity only gives the potency in arbitrarily
restricted conditions, but it has been found to give
surprisingly constant results in different labora¬
tories (jrieuse, 1948). The concentration of an
agonist needed to have a standard effect may vary
enormously, but the concentration of an antagonist
for a standard effect seems to vary much less.
The pAs provides a measurement of the threshold
concentration which just produces a small effect.
The pai0 can generally be estimated more accurately
and the conditions are such as to ensure that the
antagonist is fairly potent. To estimate the pAx
it is necessary to expose pieces of tissue to various
concentrations of the antagonist and to estimate in
each case whether x is greater or less than the
required/
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required value. bchild (1947) estimated the pAa
by first getting a constant effect with a constant
dose of agonist alone and then combining double
this dose with a suitable concentration of the
antagonist, and observing whether the effect pro¬
duced at the standard time was greater or less than
the original effect. The concentration for equal
effects was then estimated by interpolation. This
is probably the most satisfactory method of making
accurate comparisons between antagonists, but may
be a laborious way of studying the effects of a
long series of drugs whose properties are at first
quite unknown and whose effects may increase almost
indefinitely with the time of exposure. Another
method of estimating the potency of antagonists is
described later,
methods.
Hat's uterus in oostrous was found by
Lr3pamer (1952b) to be particularly sensitive to
5-hydroxytryptamine and this tissue has been used in
the experiments described here. The technique was
the same as that described on P.40. The small
bath/
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bath was connected to two reservoirs, one containing
the ordinary de Jalon's solution and the other, an
appropriate concentration of the antagonist. When
the effect of an antagonist had to be studied, the
bath was filled from the reservoir containing the
antagonist.
This preparation was cnoseu for this work mainly
because simple indole compounds such as gramlne were
found to depress the response to 5-hydroxytryptamine
in concentrations which did not depress the response
to other drugs. When tested on other tissues such
as the guinea-pig's Ileum, the effect of gramine
appeared to be less specific, and when sufficient
concentrations were used to depress the response to
5-hydroxytryptamine, the response to other drugs was
also depressed. In the experiments described here,
acetylcholine was applied as a control drug in doses
causing similar sub-maximal effects to those due to
5-hydroxytryptamine. The statement that the effect
was specific means that the response to 5-hydroxy¬
tryptamine was depressed by doses of the antagonist
which did not affect the response to acetylcholine.
The preparations which gave constant responses
to/
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5-hydroxytryptamine were used for these experiments.
A separate piece of a uterine horn was used for each
experiment to avoid errors due to the persistence of
antagonistic effects. All comparisons between the
various drugs were made on separate pieces of the
uterus.
Results.
A dose of 10 - 15 ng of 5-hydroxytrypta-
mine (calculated as base) generally caused a suitable
contraction when added to the bath (2 ml). Rome
such dose was added at regular intervals (3-5min.)
until a regular response was obtained. The dose was
then altered and a curve constructed by plotting the
height of the response against the dose. The drugs
to be tested as antagonists were then added in an
initial concentration of 10 (1 ^g/ml) and 5-hydroxy
tryptamine was reapplied. The concentration of the
antagonist was maintained in the bath for 60 minutes,
either by adding fresh doses whenever the fluid
was changed or by adding the drug to one of the
reservoirs from which the bath could be refilled.
If the effect of 5-hydroxytryptamine was not
definitely diminished, higher concentrations of the
potential/
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potential antagonists were tried. When the effect
of 5-hydroxytryptamine was diminished, the dose of
5-hydroxytryptamine was increased until the response
was 50 per cent of the maximum response at the
beginning of the experiment, or until it became
apparent that this result could not be achieved.
Time relations and dose effect curves.
The effects of active and specific
antagonists were calculated in terms of the dose
ratio (A/A© ) by comparing effects in the presence of
the antagonist with the initial dose effect curve.
Pig.33 shows an experiment of this kind with lysergic
acid diethylamide. After the dose effect curve of
5-hydroxytryptamine was plotted, lysergic acid di¬
ethylamide in a concentration of 10 pg/l. was added
to the bath at 45 minutes and this concentration was
maintained in the bath for 60 minutes or more. After
3 minutes contact with lysergic acid diethylamide, a
dose of 20 ng of 5-hydroxytryptamine produced an
effect equal to that caused by 10 ng of 5-hydroxy¬
tryptamine at the beginning of the experiment. The
dose ratio (A/Ao ), therefore, was 20/10 after 3




Rafc's uterus - 2 ml. bath
Measurement of the dose ratio (A/A0)
HT - 5-hydroxytryptamlne - doses In ng
5 MO- 5-methylgramine (1 mg/l.) added to
de Jalon's solution at 37 mln.
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5-hydroxytryptamine produced an effect similar to
that caused by 4 ng of 5-hydroxytryptamine in the
absence of lysergic acid diethylamide and the dose
ratio became 50/4. This ratio went on increasing
with time and after 27 minutes it was 200/7, after
43 minutes, 300/6 and after 59 minutes, 350/6.
A similar experiment with 5-methyl gramine is
illustrated in Fig. 34. A concentration of 1 mg/l.
of 5-methyl gramine was maintained in the bath from
37 minutes for an hour. Immediately, the responses
to 13 and 20 ng of 5-hydroxytryptamlne were completely
suppressed, but after 15 minutes of the exposure to
the antagonist, when the dose of 5-hydroxytryptarrlne
was increased to 50 ng it caused an effect equal to
about that caused initially by 2 ng of
5-hydroxytryptamine in the absence of 5-methyl gram¬
ine. The dose ratio was 50/2. It became 100/3
after 27 minutes and 200/5 after 43 minutes. After
about 40 minutes of the addition of 5-methyl gramine
to the da Jalon's solution, the dose ratio did not
increase and remained more or less at the level of
40,












Relation between dose ratio (A/Ae in log) and time
Dlbenamlne
LSD - lysergic acid diethylamide 0-
DHE - dlhydroergotsmine
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before and after the antagonist were carefully
selected. The ordinary dose effect curve of 5-
hydroxytryptamine was plotted in every case and if
a dose corresponding to a particular height of the
response was not available in the original series,
it was read from the smooth curve constructed.
These ratios were then plotted against time and
the curves for various concentrations of the differ¬
ent compounds compared (Pig. 35 and 36 ). Such
curves were constructed only for those compounds
which gave a dose ratio of 10, or higher, and had a
specific anti-5-hydroxytryptamine action. The
shapes of the curves obtained in this way may vary
considerably. The three compounds shown in Fig.35
were the most active compounds tested when judged
by their effects after 1 hour, but these effects
developed very slowly and after 10 minutes these
compounds showed very little effect in the low con¬
centrations used in these experiments. The effect of
dihydroergotamine was particularly slow to develop.
Pig .36 shows similar curves for 5 derivatives
-e














Relation between dose ratio (a/a0 in log) and time
Conon. 1 mg/l.
5B • 5-benzyloxy gramine m "" "' ®
6B - 6-benzyloxy gramine Q ^
5M • 5-methyl gramine
6M - 6-methyl gramine
4M - 4-methyl gramine
A-
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Most of these effects were also slow to develop.
The effects of most of the compounds com¬
plete within 60 minutes In the concentrations used
in the experiments. Sometimes, with most active
compounds even after 60 minutes it was impossible
to be sure that the effect was complete, but long
times introduce errors of their own and 60 minutes
was adopted as the standard time at which measure¬
ments were made.
In low concentrations (10 ^g/l.) the effects
of lysergic acid diethylamide, dibenamlne and di-
hydroergotamlne showed more or less a state of
equilibrium after 60 minutes but with higher concen¬
trations Of these drugs, the effects went on
Increasing Indefinitely. The effects of dihydro-
ergotamine In a concentration of 50 (ig/l. as shown
In Pig.35 was still Increasing even after 60
minutes. In a concentration of 10 Hg/l. dihydro-
ergotamine did not give a high dose ratio, but
lysergic acid diethylamide and dibenamlne were very
active at this dose level.
Dlhydroergocornine in the concentration used
(20 |Xg/l.) to give a specific effect caused a maximum
dose/
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dose ratio of 8.3 after 60 minutes. The effect
continued to increase with this dose even after 1
hour. Higher concentration (50 yg/l.) of this com¬
pound produced an unspecific effect. Dihydroergo-
kryptln was not very active. Even in a concentration
of 100 lAg/l* the dose ratio increased only to 9.0
after 60 minutes. Its effect in this concentration
was also progressive. In higher concentrations, it
sometimes produced contractions and spontaneous
activity. The log dose effect curves of 5-hydroxy-
tryptamine in the presence of these antagonists were
not therefore, properly studied.
The effect of 5-benzyloxy gramine was more
progressive than that of 6-benzyloxy gramine. The
effects of both these compounds were complete after
about an hour. The dose effect curves of 5-hydroxy-
tryptamlne in the presence of the two benzyloxy
gramines were also not properly studied as it took a
long time for their effects to be completed.
The effects of methyl gramines were complete
earlier (Pig.36 ). With 1, 5 and 6 methyl gramines,
the state Of equilibrium was established after 30-40




was complete within 10 minutes. 1-methyl gramine
did not shox? much activity in the concentration used
(1 mg/l.). The dose ratio with this compound rose
to the maximum figure of 6.6. The log dose effect
curves of 5-hydroxytryptamine in the presence of
methyl graminea were identical in slope with the log
_
dose effect curves in the absence of these drugs.
Fig.37, shows that the log dose effect curve of
5-hydroxytryptamine in the presence of 6-methyl
gramine (1 mg/l.) is similar in slope to the log dose
effect curve of 5-hydroxytryptamine in the absence
of this compound. The dose ratio (k/k0) of methyl
gramines, therefore, seemed to be independent of the
effect y.
The four derivatives of tryptamine; 2-methyl
tryptamine, N.K.dimethyl tryptamine, a-a-dimethyl
tryptamine and a-ethyl tryptamine also showed specific
but feeble anti-5-hydroxytryptamine effects. Their
'
dose ratios did not increase to more than 10 in the
ordinary concentrations used (1-10 mg/l.). N.N.-di¬
methyl tryptamine which was the most active from this
series, gave a dose ratio of 10. The effects of all
these tryptamine derivatives were complete in about
half-/
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half-an-hour. The log dose effect curves of 5-
hydroxytryptamine in the presence of these compounds
were similar In slope to the original log dose effecl
curves of 5-hydroxytryptamine. Pig.38 shows that
log dose affect curves of 5-hydroxytryptamine in the
presence and absence of 2-methyl tryptamine are
similar in shape.
The equilibrium state was established within 10
minutes with 5-amino-3-ethyl-2-methyl indole. The
shape of the log dose effect curve of 5-hydroxytrypta-
mine in its presence was also similar to the shape
of the log dose effect curve in the absence of this
compound (Pig.39).
This compound was synthssised by Woolley and
£haw (1952) and reported as a potent anti-5-hydroxy-
tryptamlne agent. It did not show much activity with
the test used in this study (Table III ) in the
concentrations employed (5 mg/l.). Erspamer and
Ottoienghi (1953) also reported that the anti-
enteraaina activity of this compound was weak.
However, Woolley and Ehaw employed a different kind
of test. They tested it on a ring-shaped segment
of sheep carotid artery. k maximal contraction
(l/3 decrease in diameter), of the artery ring was
produced/
Figure 38
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produced by 0,2 *ig per ml of 5-hydroxytryptamine.
Half maximal antagonism was observed with 5-10 p-g
of this analog. This compound proved a failure in
clinical trials (hpies and Stone, 1952; Iverson and
Bull, 1953; Page and McCubbin, 1953b).
The observation of Woolley and Shaw that the
corresponding nitro compound (Table IV) was inactive
in vitro was also confirmed by testa employed In the
present stud^, in the ordinary concentrations as
used for other compounds but the experiments with
this compound were unsatisfactory because it was so
insoluble. The effect with 6-amino-2:3-dimethyl
indole continued to increase for an hour or so in
the concentrations used (5 mg/l.)
6-amino-tetrahydro carbazole was the only con-
pound from the carbazole derivatives which showed
a specific effect but was feeble in its action. The
effect of this compound In the concentration used
(5 mg/l.) was complete within 10 minutes and the
pattern of the log dose effect curves of 5-hydroxy-
tryptamine with this compound was the same as that
described above.
When the experiments were repeated, the dose
ratio/
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ratio in most cases gave constant results and only
in few instances the results were variable. Such
experiments were repeated with few compounds.
The experiments with time relation showed that
with most active drugs the block developed gradually
and went on increasing indefinitely while with less
active compounds the effects were complete within
30 minutes.
The drug ratio.
The drugs can be compared with one
another by measuring the effect produced after 60
minutes. This method can however, only be used
when a concentration is found in which all the drugs
have some effect. Some of the drug3 in the present
series had no effect at all in a concentration of
.6
10 but were effective in higher concentrations;
others were effective in lower concentrations. The
opinion has already been expressed that the most
satisfactory general index of the activity of
antagonists is the pax, but quicker results may be
obtained by estimating the drug ratio, which is equal
to the ratio of the concentration of the agonist to
the concentration of the antagonist when the response
is/
Figure 40
i i i i i i i i i i i i i i i i i i i i i i i
HT HT HT HT HT HT HT HT HT HT HT HT HT HT HT HT HT HT HT HT HT HT HT
20 20 25 30 10 15 17 5 20 30 50 IOO 200 50O 500 500 50O 5O0 500 500 50O 800 IOOO nC^
O 4 8 12 15 20 24 28 ^ 32 3 6 40 44 48 52 56 60 64 6 8 72 76 BO 84 88min.
6 BOG
Rat's uterus - 2 ml. bath
Measurement of drug ratio (A/B)
HT - 5-hydroxytryptamlne
6-BOG - 6-benzyloxy gramlne (1 mg/l.) added to
de Jalon's solution at 29 mln*
129.
is 50 per cent of the initial maximum response.
Estimates of this quantity are unlikely to give
reliable results when the dose ratio (A/A0) is small
and the concentrations were tnerefore always high
enough to produce a dose ratio of at least 5 and
generally much more.
This method of calculation, which has often been
used before, is convenient because it can be used to
compare results when different concentrations of
antagonists are used, as is necessary when the
activities vary widely. It is more convenient
than the pAa In preliminary screening tests because
an estimate can often be obtained in a single experi¬
ment using only one concentration of the antagonist.
Fig. 40 illustrates such an experiment with
6-benzyloxy gramlne. A dose of 30 ng of 5-hydroxy-
tryptamine produced a maximum effect on the rat's
uterus. 6-benzyloxy gramlne (1 rng/l.) was then
continuously maintained in the bath from 29 minutes.
It caused a marked decrease in the effect of 5-
hydroxytryptamine, and the activity continued to
increase. Higher doses of 5-hydroxytryptamine were
applied at intervals to overcome this block and to
get/
Figure 41
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get a response which was 50 per cent of the Initial
maximum effect. The height of the response was
kept more or less at the level of 50 per cent of the
initial maximum response and the doses of 5-hydroxy-
tryptamine which would give this height of response
were always aimed at. After 51 minutes (corresp¬
onding to 80 min. in Pig. 40 ) a dose of 500 ng of
5-hydroxytryptamine in a 2 ml bath produced a
response which was equal to 50 per cent of the
initial maximum effect. The drug ratio, therefore,
was 250/1000 = (l/4).
A similar experiment with dihydroergotamine is
shown in Pig. 41. A dose of 100 ng of 5-hydroxy-
tryptamine in a 2 ml bath in the presence of dihydro¬
ergotamine (lOp-g/l.) after 63 minutes gave a response
which was 50 per cent of the initial maximum response.
The drug ratio in this case was 50/10 = (5).
The results shown in Tables HI and IV were
obtained in this way. The drugs listed in Table III
had a specific antagonistic effect to 5-hydroxy¬
tryptamine and the compounds collected in Table IV
had an unspecific effect as these drugs depressed the
response to acetylcholine. Most of these drugs
decreased the response to 5-hydroxytryptamine more
than/
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than acetylcholine and a few compounds suppressed
the effect of acetylcholine as much as, or more than,
the response to 5-hydroxytryptamine.
When the drug ratio is less than one it is given
as a fraction in the belief that this is easier to
remember than a decimal. The compounds in Table III
are arranged according to their potencies and chemi¬
cal structure but compounds in Table IV are grouped
mainly according to their chemical constitution.
Most of the compounds provided for testing were
very insoluble and it was found possible to dissolve
them in a small volume of ethyl alcohol. Further
dilutions were made up with de Jalon's solution and
almost In all cases the sample remained in solution
by this method but where it precipitated it was re-
dS.ssolved by the addition of more alcohol. The
final concentration of alcohol in the bath was deter¬
mined In all these cases. The inhibitory effects o
different concentrations of alcohol on the response
of rat's uterus to 5-hydroxytryptamine were found.
Alcohol in concentrations greater than 0.25 per cent
in the bath Inhibited the response of the rat's uterus
to 5-hydroxytryptamine. When the test solution con¬
tained alcohol In these concentrations, the antagon¬
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5-benzyloxy gramine 1/2.4 Dissolved in warn
acidic normal
saline solution.
X-1 '■ ■1 1 - ' 4
6»benzyloxy gramine 1/4 Dissolved in warn
acidic normal
saline solution.
5-methyl gramine 1/10 Soluble in acidic
normal saline
solution.
6-metbyl gramine 1/16 Soluble In acidic
normal saline
solution.
4-methyl gramine 1/28 Soluble in acidic
normal saline
solution.




N: N: dime thy ltryptamlne 1/40 Eoluble in acidic
normal saline
solution.
a-a-dimethyl tryptamine 1/72 Easily soluble
in normal saline
solution.
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5-hydroxy indole, 6-hydroxy indole and tryptophol had
very little or no effect, on the response to 5-hydroxytryptamire
in the concentrations used (10-100 mg/l.). The response to
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With these compounds, the drug ratio could not be
accurately measured as the standard response of 50 per
cent of the initial maximum effect could not be elicited
in the highest concentration of 5-hydroxytryptamine
employed in these experiments (5-20 pg in 2 ml bath).
These compounds were inactive in the concentrations
which were used to find the drug ratios for other
compounds.
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The drug ratios at different concentrations were
estimated for some of the specific and most active
compounds. The results which are given In Table V
appear to be more or less constant when low concen¬
trations of these drugs were used. With higher
concentrations of dlbenamlne, lysergic acid diethyl¬
amide, dihydroergotamine and 5-benzyloxy gramine, the
drug ratio became very high. It appears that with
these drugs there Is a critical range of doses which
gives a more or less constant drug ratio but when
that range is exceeded, the highest concentration of
the agonist used in the experiments either did not
give any effect or failed to produce the standard
response of 50 per cent of the maximum effect. Such
a block may be called unsurmountable (surmountable
for competitive, P.113. It has been described as
non-competitive or absolute (Nickerson, 1949) and is
similar to the type of antagonism where the log dose
effect curve after the antagonist becomes flatter when
compared with the original log dose effect curve
(schild, 1949). The difference in dose levels of
these antagonists to produce a surmountable and an un
surmountable block was very narrow. Table V
shows/
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shows that a twofold increase in the concentration
of dihydroergotamine used to give a surmountable
effect caused an unsurmountable inhibition of the
response to 5-hydroxytryptamine. However, dibenamine
and 5-benzyloxy gramine also suppressed the response
to acetylcholine in these high concentrations, while
the tivo ergot alkaloids had no effect on its response
The effect of lysergic acid diethylamide and dihydro-
ergotamine therefore remained specific even when the
block became unsurmountable, while dibenamine and 5-
benzyloxy gramine caused an unspecific effect with
the unsurmountable block.
The unsurmountable type of effect was not
possible to show with 5-methyl gramine as it pro¬
duced stimulation of the uterus in higher concen¬
trations (10 mg/1.). It rather showed a decrease
in the drug ratio as is apparent from Table V
when a surmountable effect was obtained with higher
concentrations The effect of acetylcholine was
also inhibited with this high concentration of 5-
methyl gramine. In a few cases where the experiment
were repeated using the same concentration of the




Drug ratios at different concentrations.
Kames of the compounds Concentrations
M-g/1.
Drug ratio



























With these concentrations, the response to
acetylcholine was also depressed and the
effect therefore was unspecific.
145.
fche same figure. Most of the compounds studied in
the present series showed an unspeolfic effect. A
large number of these compounds were very insoluble
and the effect of alcohol (solvent) interfered with
some of the results. However, 2-acetyl indole
oxime, aceto nitrites, amino indoles and carbazoles
and nitro carbazoles inhibited the response to 5-
hydroxytryptamine to a much greater extent than the
response to acetylcholine.
The pAx.
Some of the more potent drugs detected
by the method described above were then studied in
more detail and estimates made of the pAs
When curves have been obtained like those In
Pigs. 35 and 36 showing the relation between the
dose ratio and time, it is possible to read directly
from the curve the time corresponding to any given
dose ratio (x), and thus to calculate the pAx
corresponding to this time.
The pAs was estimated by a method rather differ¬
ent from that used by Schild (1947). A response
equal to 50 per cent of the maximum effect was first
obtained/
Figure 42
HT HT HT HT HT HT HT
20 24 16 16 16 16 nCV
O 4 8 12 16 20 24mm' „>
hat's uterus - 2ml. bath
Measurement of pAs
HT - 5-hydroxytryptamine
LSD - lysergic acid diethylamide
(lpg/l.) added to de Jalon'
solution at 9 min.
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obtained to a dose of 5-hydroxytryptamine, and then
double this dose of 5-hydroxytryptamine was applied
in the presence of a suitable concentration of the
antagonist. This double dose of 5-hydroxytryptamine
was repeated at intervals and the pA2 value was taken
at a time when the response to the double dose of
5-hydroxytryptamine in the presence of the antagonist
was equal to the original effect produced by a single
dose. 'Then the responses were not equal, the approx¬
imate time, when the effect was slightly higher
before and slightly lower after, was taken for the
pAs value. Pig.42 shows how these estimates were
mad®. A dose of 20 ng of 5-hydroxytryptamlne pro¬
duced a maximum effect and a response equal to 50
per cent of the maximum effect was obtained with a
dose of 3 ng of 5-hydroxytryptamine. Lysergic acid
diethylamide in a concentration of 1 ^g/l. was then
added to the bath at 9 min. and maintained thereafter.
A dose of 16 ng of 5-hydroxytryptamine was then
applied ana repeated at intervals. The response to
the double doss of 5-hydroxytryptamine after 7 min.
of the application of lysergic acid diethylamide was
higher and after 11 min. It was lower than the
original/
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original effect of a single dose. The pAs for
lysergic acid diethylamide was therefore taken after
9 minutes to be (10~9) 8.5 (mol. wt. of LSD 323).
A similar experiment with 5-benzyloxy gramine
is Illustrated in Pig. 43. In this experiment, a dose
of 13 ng of 5-hydroxytryptamine produced a maximum
effect and a dose of 8 ng of 5-hydroxytryptamine gave
a response which was 50 per cent of the maximum
effect. The control drug, acetylcholine, in a dose
of 40 ng caused a submaximal response. 5-benzyloxy
gramine in a concentration of 100 M-g/l. was main¬
tained In the bath continuously from 25 minutes and
doses of 16 ng of 5-hydroxytryptamine applied at
intervals. The response to this double dose of
5-hydroxytryptamine was higher after 7 minutes and
smaller after 11 minutes of the exposure to the
antagonist when compared to the original effect of
a single dose. The pA3 for 5-benzyloxy gramine was
mm7
taken after 9 minutes as (10 ) 6.44 (mol. wt. of
5-benzyloxy gramine 230).
Such results cannot of course, be used directly
to compare one drug with another because the time








5-BOG - 5-benzyloxy gramlne (100 ng/1,)








The relation of pAa to time.







As the effects of dibenamine, lysergic acid diethyl¬
amide, dihydroergotamlne and 5-benjsyloxy gramine
continued to increase for an hour or so, the estimates
of pAa were made at different time intervals up to
1 hour. ¥iJhen, however, a series of different con¬
centrations of these antagonists had been used, the
relation between pAa and time was plotted as shown
in Fig.44* The pA8 for these drugs continued to
increase for at least 30 minutes. From such curves,
the pAs corresponding to an arbitrarily fixed time
can be determined.
The pAs values for dihydroergokryptin, 5-methyl
gramine, mepyramine, diphenhydramine and atropine
were also determined.
As pA measurements are more variable after long
periods of contact with the antagonist than after
short periods (&child, 1947), 10 minutes contact
with the antagonist was considered to give a reliable
result. Table VI gives the pAs values for various





Results of pAa determinations.






















pAs for the last three drugs reached a steady value
In less than 10 minutes. This Is in accord with
the behaviour of non-specific and less active
antagonists (Schlld, 1947). The pA^, gave fairly
constant results when the experiments were repeated.
The pAa estimate of 8.5 for lysergic acid diethyl¬
amide/'
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diethylamide corresponds favourably with the figure
of 8.7 as reported by Gaddum (1953b) for the same
compound.
Stimulation followed by specific depression of the
tryptamine receptors.
The 12 indole compounds shown in Table
VII caused stimulation of the uterus but this was
followed by a specific depression of the tryptamine
receptors. These drugs were kept in the bath for
10 minutes in the concentrations given in the table
and then washed out. When the muscle had relaxed
and the spontaneous activity ceased, it gave a dim¬
inished response to 5-hydroxytryptamine and a normal
response to acetylcholine. The response to 5-
hydroxytryptamine gradually recovered. These com¬
pounds thus behaved like 5-hydroxytryptamine itself
which also causes stimulation followed by depression
of the tryptamine receptors (Gaddum, 1953a). Such
types of experiments were difficult to reproduce
with gramlne methosulphate, 2-methyl gramine and
bufotenln. They caused marked contraction and
spontaneous activity which persisted for a long time
when these drugs were removed from the bath. Most
of/
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of these drugs In low concentrations when they did
not cause any contraction potentiated the response
to 5-hydroxytryptamine, Such potentiation of the
response to 5-hydroxytryptamine was especially
observed with gramine methosulphate, 2-methyl
gramine and 6-raethyl tryptamine in concentration of
10 mg/l,
The three gramine derivatives usually caused
1
a good contraction in a concentration of 5-10 mg/l.
They initiated much spontaneous activity of the
uterus which interfered with the experiments.
Occasionally, these compounds did not give any con¬
traction but when kept for more than 10 minutes in
the bath started the muscular activity. When their
stimulant effects were compared with that of 5-
hydroxytryptamine on the rat's uterus, they were about
500-1000 times less active than 5-hydroxytryptamine.
Bufotenin in a dose of 100-300 lig/l. gave a
satisfactory response and was 15-40 times less active
than 5-hydroxytryptamine on the rat's uterus.
Krspamer (1952c) found bufotenin l/lO as active as
enteramine on the rat's uterus.
6-hydroxytryptamine was very feeble in its




Specific, but stimulant Indole compounds
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the uterus and was about 10,000 times less active
than 5-hydroxytryptamlne. The tryptamlnes usually




5-hydroxytryptamine was 500-1500 times more
active than the various tryptamine derivatives.
Erspamer (1952 c) reported 1-methyl tryptamine to be
about 100 times less active than 5-hydroxytryptamine
when tested on the rat's uterus Tryptamine itself
was more active than its methyl and lsopropyl deriva¬
tives. Among the methyl tryptamines themselves, the
few observations which were made indicated that 5-
methyl tryptamine was slightly more active than the
other methyl derivatives. There was not much differ¬
ence between the activities of 1, 4, 6 and ?-methyl
and a-methyl tryptamines. N-isopropyl tryptamine,
however, seemed to be comparatively less active than
the methyl tryptamines.
The initial stimulant effect of these compounds
was also found to be specific, since it could be
specifically antagonised by small doses of other
indole compounds whoch had been found to be specific
antagonists of 5-hydroxytryptamine.
Since the three derivatives of gramines
occasionally, did not cause contractions, the inhibi¬
tion of their stimulating effect by other known
antagonists of 5-hydroxytryptamlne was not studied.
The response to bufotenin was suppressed by
5-benzyloxy-/
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5-benzyloxy gramine (500 M-g/l.) and dihydroergotamlne
(100 Hg/l.). The effects of 6 -hydroxytryptamlne, 1,
5, 6 and 7-methyl tryptamines were blocked by 5-»ettayl
gramine in a concentration of 1 mg/l.
The response to 4-methyl tryptamine, a-methyl
tryptamine and N-lsopropyl tryptamlne were abolished
by 4-methyl gramine (1 mg/l.).
i> •
stimulation followed by unspeciflc depression
of the receptors.
The 10 compounds shown in Table vm caused
stimulation of the uterus in the concentration used
but this was followed by unspecific depression of the
uterus as the response to acetylcholine was also
inhibited.
These drugs were kept in the bath for 10 minutes
usually in concentrations given in the table and then
washed out. when the muscular contractions had
ceased, the subsequent direct effects of both 5-
hydroxytryptamine and acetylcholine were diminished.
Concentrations lower than those shown in the table
neither caused any contractions nor had any effect on
the responses to 5-hydroxytryptamine and acetylcholine.




Unspecific stimulant indole compounds.
















did not show much inhibition of the effects of 5-
hydroxytryptamine in concentrations of 10 mg/l.
but when higher concentrations (25 mg/l.) were used,
no stimulant effect was observed and the responses
to both 5-hydroxytryptamine and acetylcholine were
markedly inhibited. jbven increasing the dose of
5-hydroxytryptamine to 400-2000-fold did not produce
any effect.
7-amino 2;3-dimethyl indole produced slight
inhibition of the effects of 5-hydroxytryptamine and
acetylcholine in the concentrations used (25 mg/l.).
The two 4-amino indoles showed a delayed stimulant
effect. The muscle started contracting gradually
after the drugs had been in the bath for about 8
minutes. It went into a marked spasm and took 45
minutes to relax after the drugs had been removed
from the bath.
Reversibility
The recovery of the responses to 5-
hydroxytryptamine after the antagonists were removed
from the bath was observed for 1-2 hours before it
was deemed irreversible or only partially reversible.
The recovery of the response to 5-hydroxytryptamine
was/
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was dependent on the concentration of the antagonist
used and on the length of time the antagonist was in
contact with the muscle. In general, these effects
were studied with the various antagonists in the
concentrations used for finding the ratios,(Table III
and IV)« In most cases, the time of contact with the
mu scle
uterine/was 1 hour.
Reversibility of specific antagonists.
The effects of dibenamine, lysergic acid
diethylamide, dihydroergotamine and the various other
ergot alkaloids were partially reversible when used
in low concentrations (1-10 Mg/l.) but higher concen¬
trations ( 10 M-g/l*) produced an irreversible
block. Dibenamine, however, seemed to be the most
potent as the response to 5-hydroxytryptamine showed
very slight recovery even when low concentrations
of dibenamine were employed.
The antagonistic actions to the response to 5-
hydroxytryptamine,of the benzyloxy gramlnes;were
reversible in concentrations of 10 Mg/l*;, partially
reversible in concentrations of 1 mg/l. and irre¬
versible in higher concentrations (5 mg/l.).
The/
158.
The methyl gr&mines showed a reversible effect
in concentrations of 10-100 pg/l., but with concen¬
trations of 1 mg/l. there was partial recovery of
the response to 5-hydroxytryptamine.
The sensitivity of the uterine muscle to 5-
hydroxytryptamine slowly recovered after the various
tryptamine derivatives were removed from the bath.
In the case of 5-amino-3-ethyl-2-methyl indole,
the recovery was almost immediate. On the other
hand, the response to 5-hydroxytryptamine after 6-
aminotetrahydrocarbazole was removed,showed a gradual
recovery to the original level.
Reversibility of unspeclflc antagonlsts.
In most of these cases, the effects of the
control drug, acetylcholine, recovered more rapidly
than the responses to 5-hydroxytryptamlne. After
treatment of the muscle with the various methyl
derivatives of Indole, the response to 5-hydroxy¬
tryptamine showed a slow recovery to normal in every
case •
The antagonistic effect of3-carbethyoxy-5-
methoxy-2-methyl indole proved to be readily revers¬
ible in contrast to that of 2-methyl-3-acetyl indole
from which no recovery was obtained.
In/
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In the series of Indole derivatives containing
an amino group attached to the ring, only 7-amino-
3-ethyl-2-methyl indole produced an Inhibition of
5-hydroxytryptamine response from which complete,
albeit slow, recovery was observed. The other amino
derivatives exerted antagonistic effects which were
irreversible or only partially reversible.
The inhibitory actions of the acetonitriles
proved to be fleeting since the muscle rapidly re¬
gained Its sensitivity to 5-hydroxytryptamlne after
removal of the antagonists from the bath. It Is
interesting to note that with p-indolyl acetonitrlle
the sensitivity of the muscle to 5-hydroxytryptamine
returned to the original level more rapidly than did
the sensitivity to acetylcholine.
The nitro indole series of compounds were found
to produce irreversible or only partially reversible
block of the 5-hydroxytryptamine respose. In all
cases, the acetylcholine contractions showed a
gradual recovery.
With all the carbaaole derivatives tested, an
inhibition of the 5-hydroxytryptamine response was
obtained. On removal of the antagonist, the
response level returned to normal in every case but
the/
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the rate of the recovery varied. Gradual recoveries
were obtained with the aminotetrahydrocarbazoles and
the nitrocarbazoles while with the tetrahydro-
derivatives of the latter the recoveries were more
rapid.
N-ethyl-W-l-naphthyl-methy1-2-bromo ethylamine
(SY-2Q) and dihydroergocristine behaved in a manner
similar to dibenamine and to other lysergic acid
derivatives in so far as the recoveries of the
5-hydroxytryptamine responses were concerned.
The response to 5-hydroxytryptamine gradually
recovered to its original level when mepyramine;di¬
phenhydramine or atropine were washed out of the bath.
After treatment with the compounds which caused
stimulation followed by specific depression of the
tryptamine receptors (Table VII ) the uterine muscle
showed gradual recovery of its sensitivity to 5-
hydroxytryptamine.
The inhibition of the response to 5-hydroxy-
tryptamine was partially reversible or irreversible
with those compounds which caused stimulation followed
by unspeclfic depression. After the aminocarbazoles,
partial recovery was obtained but with the amino-




The above mentioned recovery results showed that
most of the compounds which reached equilibrium within
a short time were rather inactive and their effects
were easily reversible. borne of the unspecific
alcohol soluble compounds in the present series
showed marked inhibitory effects, but when they were
washed out. there was raoid recovery of the responses
to 5-hydroxytryptamine and acetylcholine. Such
gffects were probably due to alcohol.
Chemical structure and pharmacological action.
The indole compounds tested in this study
'"■'4
were derivatives of indole itself, or of gramine or
of tryptamine. In addition, a number of carbazole
compounds and lysergic acid derivatives were investi¬
gated. These too, may be regarded as indole deriva¬
tives since the indole nucleus comprises part of the
ring structure of these compounds.
The introduction of various substituent groups
into the parent molecule was found to effect the
pharmacological action to a degree which depended
not only on the nature of the group introduced but
also on its position in the molecule. To simplify





will be considered separately. At the outset, it
should be pointed out that many of the series were
incomplete and the conclusion drawn should therefore,
be regarded only as tentative.
Indoles (Fig.45).
The Mono Methyl indoles. With the
exception of the 2-methyl derivative, all the mono
methyl indoles showed an unspecific depression of
the sensitivity of the uterine muscle to agonists,
with the 5-methyl derivative being the least active.
Indole itself also produced an unspecific effect.
The introduction of an acetonitrile group into
the 3-position of the indole ring in indole and the
methyl indoles led to a diminution in activity which
was still unspecific. The most active of the aceto-
nitriles was 5-methyl-3-lndolylacetonitrilej the
least active being the 1-methyl derivative. The
last substance showed no activity In the ordinary
concentration (10 mg/l.) in which the other members
of the series showed some activity but when the
concentration was raised to 50 mg/l. had a marked
inhibitory effect on the 5-hydroxytryptamine responses.
It is Interesting to note that the acetonltriles were
found/
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found to produce their maximum Inhibitory effect
immediately which, in turn, was Immediately
abolished on removing the antagonist from the organ
bath.
Amino Indoles.
No monoamino indole compounds were
available for study. The amino Indoles examined
were homologues of the compounds shown by Woolley
and 5haw (1953c) to have an antagonistic effect on
the action of 5-hydroxytryptamlne on carotid artery
strips. Of the amino derivatives of 2-methyl-3-
ethyl indole,only the 5-amino compound showed a
specific antagonistic action. The other compounds
exhibited an unspeciflc effect,with the 4-amino
derivative showing, in addition, a stimulant action
on the uterus.
In the series of amino derivatives of 2:3-di-
methyl indole the 6-amino compound showed a specific
antagonistic action which was more intense than that
of the 5-amino-2-methyl-3-ethyl compound. Unfor¬
tunately, the 5-amino derivative of this series was
not available for examination. The other members of






of the uterus and an unspeclflc depression of the
muscle responses to the agonists.
Nltro Indoles.
No mononltro indoles were available for
3tudy. Structurally, most of the nitro indoles
examined were compounds analgous to the amino indoles
discussed above. All were unspecific in action. Of
these compounds, the 7-nitro-2-methyl-3-ethyl indole
,
proved to be the most active.
Hydroxy indole.
Of this series only 5- and 6-hydroxy-
indole were tested. Neither of these showed any
significant action.
Gramine (Fig.46) derivatives.
These were all good antagonists, the 5-
benzyloxy gramine showing the greatest activity. The
benzyloxy derivatives were found to he more active
than the corresponding methyl derivatives. While
the maximum inhibitory action of the methyl gramines
was reached within 30 minutes contact with the
preparation/
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preparation, that of the benzyloxy gramines
developed more slowly, taking 1 hour at least. The
position of these groups in the ring was important;
the substitution in position 5 had the maximum
effect while 6-methyl gramine was more active than
4-methyl gramine. Substitution of the hydrogen
atom on the indole nitrogen by a methyl group
decreased the activity. Gramine itself first had
a weak inhibitory effect on the 5-hydroxytryptamine
responses but this was soon masked by spontaneous
contractions of the muscle some 10 minutes after the
gramine had been introduced into the bath. The 2-
*
methyl gramine and gramine methosulphate produced
first, stimulation of the muscle and after removal
from the bath the response to 5-hydroxytryptamine was
inhibited. In low concentrations where these drugs
did not cause stimulation, the response to 5-hydroxy¬
tryptamine was potentiated In the presence of these
substances.
The substitution of a methyl group in the benzene
ring portion of the indole structure of gramine pro¬






of 5-hydroxytryptamine without causing preliminary
stimulation of the muscle by their own action.
5-hydroxy gramine unlike 5-methyl gramlne or
5-benzyloxy gramlne caused contraction of the uterus
In the doses required to produce an Inhibitory effect
of the 5-hydroxytryptamine response. No other
hydroxy compound was available for study and so the
effect of changes of position of the hydroxyl group
is not known.
Tryptamlne (Fig.47) derivatives.
Compared with the gramines, the trypta-
mlnes were feeble antagonists. N.N.dimethyl trypta-
mine, the homologue of gramine, was the most active
in this aeries. This substance had more activity
than that containing two methyl groups or an ethyl
group on the a carbon atom. In the concentrations
used;none of these compounds per se, produced stimu¬
lation of the muscle.
In the series of compounds resulting from the
introduction of a methyl group into the indole ring
of tryptamine, the position of the methyl group was





action. The compound with the methyl group in
position 2 was inhibitory to the 5-hydroxytryptamine
response and without stimulant effects on the uterus.
A methyl group in any other position on the indole
nucleus of tryptamine resulted in compounds which
caused contraction of the muscle. The substitution
of a methyl group in position 5 produced a compound
which was more potent for its stimulant action on
: ' ■ : 1 '
the uterus than the other methyl derivatives of
tryptamine.
It thus appeared that of the compounds result¬
ing from the introduction of a methyl group into the
various positions of the indole ring of gramlne, only
the 2-methyl derivative was a uterine stimulant,
„ •
while, in the tryptamine series, uterine stimulation
was a property only of those derivatives in which the
methyl group occupied a position other than the 2
position in the Indole ring.
In contrast to the marked stimulant effect of
5-hydroxytryptamine on the uterus, 6-hydroxytrypta-
mine was to all intents and purposes, inactive. Like
5-hydroxytryptamine itself, high doses of the 6-





action of 5-hydroxytryptamine. Compounds with the
hydroxyl group in other positions were not examined.
Carbazolea (Pig.48).
In the earbazole series, only amino and
nitro derivatives of carbazole and 1;2:3:4; tetra-
hydrocarbazole have been studied.
Of these, only 6-amlno l:2J3:4:tetrahydro-
carbazole had a specific action. The maximum
inhibitory effect of this compound against 5-hydroxy-
tryptamine was reached within 10 minutes but was
feeble. It is interesting to note that the 6
position in the tetrahydrocarbazole compound
corresponds to the 5 position In the Indole structure.
The corresponding 5-amino derivative had a stimulant
action on the uterus which was lacking with the 6,
7, and 8-amino compounds. The 5,7 and 8-amino
derivatives showed an unspecific decrease of the
response to 5-hydroxytryptamine.
The corresponding nitro-1:2:3:4:tetrahydro¬
carbazole s showed no stimulant action but possessed
an unspecific antagonistic action to the response
of/
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of the uterus to 5-hydroxytrypfcamine. The 5-nifcro
compound proved to be the most potent.
The analagous monoaminocarbazoles all possessed
a stimulant action not shown by the corresponding
nitro derivatives. Both the amino and nitrocarba-
zoles were unspecific inhibitors of 5-hydroxytrypta-
mine.
Some of the apparently anomalous findings
observed, particularly with the unspecific compounds
might be due to the fact that most of these compounds
were very insoluble and the effect of the solvent
used (alcohol) might have interfered with the result
However, the above study of structure-activity
relationship of the various indole and carbazole
compounds revealed the following characteristic
features for their anti-5-hydroxytryptamine actions.
1. The presence of the side chains of gramine
and tryptamine compounds were important both for
specificity and potency of inhibitory action against
5-hydroxytrypfcamine.
2. In most of the cases, the substitution of
the 5 position in the indole ring (or the correspond¬





or an amino group increased the specificity and the
activity of the compounds. Next in order was
substitution in the 6 position.
3. Substitution of the hydrogen atom on
the indole nitrogen by a methyl group decreased the
activity.
4. The introduction of a hydroxyl group
into the indole ring produced a drug with little or
no activity.
5. All the nlfcro derivatives produced an
unspecific effect.
Lysergic acid (Fig. 49) derivatives.
Of the various compounds allied to the
ergot alkaloids, lysergic acid diethylamide was the
most active and ergometrine the least. Table IX
shows the composition of the various derivatives of
lysergic acid tested.
Again, a comparison of the lysergic acid
derivatives showed that the composition of the side
chain attached to the carboxyl group mainly




Composition of the lysergic acid derivative^
Lysergic acid diethylamide Lysergic acid diethylamide




























Ergometrine Lysergic acid Propan-l-ol-2-
amide
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The diethylamide group, as in lysergic acid diethyl¬
amide had the maximum effect while the propan-l-ol-
2-amide group as in ergometrlne had little effect.
The inhibitory actions of the other lysergic
acid derivatives seemed to depend mainly on the
polypeptide moiety which is present in these com¬
pounds and absent in ergometrine.
The difference in the potencies of dihydro-
ergotamine from the other dihydro derivatives of
lysergic acid might be due to the variations in
amino acid constitution. The fact that the
potencies of dihydroergotamine and dihydroergo-
cristine were greater than those of dlhydroergo-
cornine and dihydroergokryptine suggests that the
presence of a phenylalanine group in the molecule
enhanced the anti-5-hydroxytryptamine activity.
The reason for the unspecific action of dl-
hydroergocristine and the narrow range of specificity
with dihydroergocornine (specific in concentrations
50 pg/i.) is not readily apparent. Perhaps
the presence of dimethyl pyruvic acid in these





Comparison of the potencies of ergotamine and
dihydroergotamine Indicated that hydrogenation
Increased the 5-hydroxytryptamine blocking activity.
This is also true for their anti-adrenaline action
(Nickerson, 1949).
Dlbenamine (Pig.50) (N,N-dibenzyl-p-chloro-
ethyl-amine) was the only p-chloroethylamine com¬
pound tested for antl-5-hydroxytryptamine activity.
It had a very marked effect which continued to
increase indefinitely and was irreversible.
Discussion.
The estimation of the potencies of the
various antagonists after an interval of 1 hour
might be criticised because of the possible change
of sensitivity of the preparation of 5-hydroxy-
tryptamlne after such a long Interval. The dose-
effect curves of 5-hydroxytryptamine were repeated
at different intervals up to 1 hour on an ordinary
preparation/
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preparation and no significant difference was found
between these curves.
Most of these measurements were taken when the
equilibrium states between the agonist and the an¬
tagonist had been established but in a few instances,
especially with some of the most active compounds it
was not possible to be sure that the effect was com¬
plete after 1 hour. Failure to establish equi¬
librium conditions may make it difficult to distinguish
between the effects of the antagonist and that of
deterioration of the preparation, but in the present
study, the control drug, acetylcholine, was often
applied at intervals to test the sensitivity of the
preparation. The sensitivity to acetylcholine did
not diminish after 1 hour in the presence of these
antagonists in the concentrations used.
The potency estimates of the most active com¬
pounds when repeated had been found to give constant
results with the pAs method. According to these
estimates, lysergic acid diethylamide, dibenamine,
dihydroergotamine, dihydroer&oKryptin and 5-benzyloxy
gramine were the most active antagonists of 5-hydroxy-
tryptamine, on the rat's uterus (in descending order
of/
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of potencies). Dihydroergocornine had more activity
than dihydroergokryptine hut was only specific in
concentrations lower than 50 pg/l.
Among these compounds, estimates of dose ratio,
drug ratio and pAs agree, except that dibenamine gave
a higher drug ratio but lower pAe value than lysergic
acid diethylamide. This difference in results might
be due to the rate of development of the blockade at
various concentrations of dibenamine. In low
concentrations (1-5 pg/l.) used for finding the pA3
values, dibenamine was less active than or as active,
as lysergic acid diethylamide, while at the higher
concentrations (10 pg/l.) used for the drug ratio
determination it was more active than lysergic acid
diethylamide. Again, the effect of dibenamine
seemed to develop very gradually in low concentrations
as compared with that of lysergic acid diethylamide.
Though the pAs value of dibenamine was low at 10
minutes, it rose to be equal to that of lysergic acid
diethylamide after 1 hour (Fig.44).
The study of time-action, concentration-action
and recovery effects showed that there were two
xypes of compounds. The most active compounds, such
as/
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as dibenamine, lysergic acid derivatives and the
benzyloxy gramines, had an inhibitory action the
intensity of which increased with time of contact
with the muscle and which was irreversible or only
partly reversible. In low concentrations they
showed a surmountable block but at slightly higher
concentrations of these antagonists, the inhibition
of the response to 5-hydro3tytryptamine became un-
surmountable.
The other type included the methyl gramines,
tryptamines, 5-amino-3-ethyl-2-methyl indole and 6-
; minotetrahydrocarbazole. Their actions were com-
|L , ;j ; .. ; . ; ' • -j
plete within 30 minutes, were less intense and were
easily reversible.
The above characteristics of the two types of
compounds have been more or less, the rule in the
present study. The blockade with the most active
compounds developed gradually and the rate and degree
of blockade depended upon the concentrations of the
drug used.
It appears that these drugs have a great
affinity for the tryptamine receptors and once they
reach their site of action in a suitable concen¬
tration, it is difficult to dislodge them. However,
an/
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an alternative explanation for their effects may be
that in low concentrations, like the less active
compounds, they merely occupy the tryptamine
receptors but in high concentrations they may poison
this structure or some other essential mechanism
which is concerned in the action of 5-hydroxy-
tryptamine. This damaged system takes, perhaps, a
long time for re-synthesis which might explain the
observed Irreversibility of their effects. Whatever
may be the explanation of the mechanism of their
actions, the various lysergic acid derivatives tested,
with the exception of dihydroergocristine, seems to
act specifically on the tryptamine receptors even in
the state of unsurmountable block in the concentration
used, while dlbenamine and5-benzyloxy gramlne extend
their toxic effects to other parts of the muscle so
that the block becomes unspecific.
Lysergic acid diethylamide was thus the most
specific and the most potent antagonist for 5-hydroxy-
tryptamlne on the rat's uterus. This substance has
also other interesting pharmacological actions. It
exerts the powerful mental effects in the human being
Utoll, 1947). In certain subjects, very small
doses/
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doses (0.02 mg) of lysergic acid diethylamide given
orally, produce alternate phases of euphoria and
depression. It produces a feeling of depersonal-
Isation or of split personality of a clearly schizo¬
phrenic nature. Among the subjective symptoms are
an impression of looking at one's self from a
distance, of having lost control of one's real
self, of having changed and become more or less,
unreal and cut off from the rest of the world.
Certain subjects experience visual hallucinations,
especially if they are in the dark or their eyes
are closed. In many cases, lysergic acid diethyl¬
amide makes the patient more accessible to psycho¬
analysis by Improving contact and facilitating the
recall of memories. It has been used for diag¬
nostic and therapeutic purposes in psychiatry.
5-hydroxytryptamine is known to be present in
the brain (Amin, Crawford and Gaddum, 1952). These
effects of lysergic acid diethylamide In normal
persons may be due to the antagonistic action of the
drug on the normal amounts of 5-hydroxytryptamine in
the brain. It may be that one of the functions of
5-hydroxytryptamine is to keep one sane.
There/
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There are, as yet, 110 experimental data to
support the idea of such a role for 5-hydroxy-
tryptamlneMoreover, lysergic acid diethylamide
does not antagonise the effects of 5-hydroxy-
tryptamlne on all tissues.
oummary
1. 4 systematic search for a potent and
specific antagonist for 5-hydroxytryptamine was
carried out. This required the selection of suit¬
able sensitive tissues and the development of
quantitative methods for analysing the notencies of
these antagonists.
2. 5-hydroxytryptamine causes contractions
of the following isolated organs: uterus, duodenum
and colon of the rat; the uterus, duodenum and
jejunum of the rabbit and the uterus, duodenum,
jejunum and ileum of the guinea-pig. It also
caused vasoconstriction in the perfused ear of the
rabbit.
3. Of these tissues, the rat's uterus, the
guinea-/
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guinea-pig's ileum, and the rabbit's ear were
especially sensitive and the effects of 5-hydroxy-
tryptamine and various possible antagonists were
tested using these preparations.
I
4. With suitable concentrations of mepyramine,
piperoxane and atropine it is possible to inhibit
the effects of histamine, adrenaline and acetylcholine
without altering the responses to 5-hydroxytryptamine.
This supports the view that 5-hydroxytryptamine acts
on specific receptors which have been called
tryptamine receptors.
5. The effects of various 5-hydroxytrypta¬
mine antagonists can be explained on the theory that
there are two types of tryptamine receptors. One
type is present in the smooth muscle of the uterus
and ear and is specially inhibited by low concen¬
trations of lysergic acid diethylamide. The second
type is present in the nervous tissue in the ileum
and is not inhibited by lysergic acid diethylamide.
6. The effect of 5-hydroxytryptamine on the
ileum is inhibited by atropine or cocaine in the same
way that the effect of nicotine is inhibited. How¬
ever/
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ever, hexamethonium suppresses the response to nico¬
tine but not to 5-hydroxytryptamine. These facts
can be explained on the theory that the ganglia in
the guinea-pig's intestine contains two types of
receptors, one of which is stimulated by nicotine
and the other by 5-hydroxytryptamlne.
7. The effect of cinobufotenin, the quartern
ary base corresponding to 5-hydroxytryptamine, is
partly inhibited by hexamethonium or by large doses
of 5-hydroxytryptamlne and completely suppressed by
cocaine. It is therefore considered to act on both
types of receptors in the ganglia in the guinea-pig's
Ileum.
3. Ephedrine potentiates markedly the action
of 5-hydroxytryptamlne on the rabbit's ear, while
choline-p-tolyl ether potentiates In low concen¬
trations and inhibits the effects of 5-hydroxy¬
tryptamine in higher concentrations. This potenti¬
ation of the effect of 5-hydroxytryptamine is
presumably due to the inhibition of amine oxidase.
9. k preliminary study with 18 indole
compounds showed that the oestrous uterus of a rat
was/
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was a suitable preparation for the quantitative
study of antagonists for 5-hydroxytryptamine.
10. Anti-5-hydroxytryptamlne potencies of
a large series of compounds were estimated by find¬
ing the drug ratio and also, In the case of active
compounds, by measuring the dose ratio and the pAs
values. All these measurements were made at the
standard time of 60 minutes.
11. The dose ratio is A/A0 where A0 = the
concentration of the agonist (HT) which has a given
effect (Y) in the absence of the antagonist and A -
the concentration of the agonist which has the same
effect In the presence of the antagonist In concen¬
trations B and at time t.
12. The drug ratio(A/B) is equal to the
ratio of the concentration of the agonist to the
concentration of the antagonist when the response is
50 per cent of the initial maximum effect.
13. The method of finding the pAa was that
described by Schild (1947) with slight modification,
and gave the most constant results.
14./
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14. With most active compounds the effects
develop gradually and are irreversible or partly
reversible while the effects of less active compounds
are complete within a short time and are easily
reversible.
15. The compounds tested were derivatives of
indole,, gramine, tryptamine, carbazole and lysergic
acid. Dlbenamine, N-ethyl-N-l-naphthyl-methyl-2-
bromo ethylamine (SY-28), mepyramine, diphenhydramine
and atropine were also investigated.
... .
_ f %% ■ t
16. Regarding the relation between chemical
structure and pharmacological action, the chemical
nature of the side chain of these compounds was found
to be important for specificity and potency in their
antagonisms to 5-hydroxytryptamine.
17. Lysergic acid diethylamide, dibenamine,
dihydroergotamine, dihydroergokryptine and 5-benzyl-
oxy gramine in descending order of potencies were the
most active antagonists for 5-hydroxytryptamine
found.
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